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Despite the wealth of studies examining the adverse health effects of ozone exposure and 
its association with increased airway inflammation, the mechanisms behind it have yet to be fully 
described. Ours and previous studies have shown that exposure to O3 results in the formation of 
electrophilic lipid peroxidation products, notably through the oxidation of cholesterol in the 
airway lining fluid. These electrophilic oxysterols are capable of forming covalent linkages with 
nucleophilic centers of proteins, particularly lysine residues, thus altering cellular signaling 
pathways. Much remains to be learned about the identity of the reactive species and the range of 
potential proteins modified by the oxysterols in the lung and the biological consequences. Using 
2D LC-MS/MS shotgun proteomics and “click” chemistry, we have generated a database of 
oxysterol-adducted proteins in airway epithelial cells treated with purified oxysterol Secosterol A 
as well as O3-derived oxysterols. Among those oxysterol-adducted proteins were LXR and 
NLRP2. O3-derived oxysterol adduction of LXR inhibits transcription of cholesterol transport 
and binding proteins and increases NF-κB activation and inflammatory cytokine signaling. 
NLRP2 is the most abundantly expressed member of the NLR family of proteins in human 
airway epithelial cells. Further, we show that exposure of epithelial cells to O3 increases NLRP2 
expression, active caspase-1 levels, and markers of inflammasome assembly, suggesting that 
NLRP2 inflammasome complexes play important roles in airway epithelial cells and more 
specifically in the context of O3 exposure and oxysterol formation. Finally, we identify that the 
iv 
 
widely prescribed anti-psychotic drug Aripiprazole (APZ) has the potential to increase 
inflammatory response in human airway epithelial cells. We determine that APZ acts as an 
inhibitor of dehydrocholestrol reductase 7, resulting in an increased cellular concentration of the 
cholesterol precursor 7-dehydrocholesterol (7DHC). Ozonization of 7-DHC produces highly 
reactive oxysterol species in comparison to cholesterol ozonization products and our data shows 
that ozonization of 7-DHC compared to cholesterol results in increased inflammatory cytokine 
expression. Potentiation of the O3 inflammatory response by APZ reveals a new paradigm of 
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CHAPTER 1: THE DUAL NATURE OF OXYSTEROLS IN THE HUMAN BODY 
1.1 Introduction 
1.1.1 Cholesterol and Oxysterols in the Human Body. 
Medical biologists and toxicologists have expressed interest in oxysterol biochemistry in 
the human body for at least the last 50 years, however, only recently have they been studied as a 
potential target for interaction with environmental stressors and as a marker of health in various 
tissues. The aim of my dissertation as a whole is to present a novel understanding of oxysterol 
formation and their biochemical properties, providing new information to researchers studying 
the impact of cholesterol and cholesterol modification by environmental exposures in human 
health. The purpose of this chapter is to introduce the reader to the function of oxysterols in the 
human body, distinguish differences in routes of oxysterol formation, and discuss their potential 
for adverse health effects. Principally, it is important to place our discussion of oxysterols in the 
context of environmental pollutant exposures and the human airway epithelium, the tissue of 
interest and focus of the primary research findings discussed in the later chapters.  
Steroid alcohols (Figure 1.1), or sterols are organic molecules with a polar hydroxyl 
group at the 3-position of the A-ring and are formed through the HMG-CoA reductase pathway 
(1-3). In humans, cholesterol is the most abundant and well-studied sterol. In general, sterols are 
necessary for key metabolic functions in normal cellular activities, most notably maintaining 
cellular membrane integrity, waste excretion, and the formation of signaling molecules like 
steroids (4). Thus, sterol concentration is tightly regulated by the human body. Sterol precursor 
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molecules as well as modified cholesterol have been associated with cholesterol homeostasis and 
transport, likely since the terpenoids and hopanoids of early bacteria (5,6). Early modified sterol 
messengers were produced through nonenzymatic forces and served to induce cellular 
cholesterol management, waste excretion, and transcription signaling (7,8). Sterol modification 
has been evolutionarily preserved as an integral process necessary for survival in a variety of 
species, including mammals.  
 
Oxidized cholesterols (oxysterols) are a form of modified sterols, which are known to 
direct biological functions like those mentioned previously. Measured concentrations of 
oxysterols in the human body vary depending on the cellular tissue, metabolic capacity, and 
health of the individual (9,10). For example, the plasma of smokers exhibits higher levels of the 
oxysterol 7β-hydroxy-cholesterol compared to nonsmokers (11,12). Under healthy conditions, 
oxysterols typically exist in trace amounts, at approximately 1000-fold less than cholesterol, 
however, their distribution throughout the individual cell and human body is not uniform and an 
increase in the oxysterol/cholesterol ratio can lead to pathophysiological outcomes (13,14). In 
order to better understand the adverse outcomes associated with oxysterols in the human body it 




1.1.2 Distinguishing Oxysterols by Function and Route of Formation 
When writing about oxysterol in the human body, route of formation and function need to 
be considered, however, making these distinctions quickly becomes increasingly complex. 
Primarily, the species of oxysterol formed depends on the precursor sterol that is oxidized. 
Depending on the sterol target, primary oxysterols exhibit either a side chain or ring modified 
oxysterol while secondary oxysterols can have multiple modifications (15). Through varied 
modifications there are a great variety of oxysterol species capable of being formed in the human 
body. The complexity intensifies as oxysterol species formation can be determined by the pH of 
the environment in which it is formed and the capacity for primary oxysterols to be quickly 
metabolized and transformed into secondary structures (16). To varying degrees, most oxysterols 
are electrophilic, in that they have the capacity to accept electrons and illicit cellular responses 
by bonding to another compound (17). Their electrophilic nature allows oxysterols to both act as 
key signaling molecules in the 
body and act as potentially 
damaging compounds with the 
capacity to bind to nucleic acids 
and proteins. As a consequence 
of the complexity governing what 
is currently known about 
oxysterols in the human body, it 
is the best practice to make 
delineations for oxysterol species 
based on route of formation.  
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Traditionally, oxysterols in the human body are split into two groups, enzymatically 
derived and free-radical derived (18,19). While the majority of oxysterols are created 
enzymatically through cytochrome P450 (CYP) hydrolysis, many unique oxysterol species are 
formed through autoxidation and other non-enzymatic metabolism and alteration. With 
exceptions, enzymatically derived oxysterols typically exhibit modification to the cholesterol 
side chain, while free-radical derived oxysterols generally exhibit modification to the cholesterol 
ring 5,6 double bond position, forming aldehyde, epoxy, and keto groups capable of electrophilic 
attack on various cellular components (Figure 1.2) (20,21). The existence of this division in the 
characterization of oxysterols has led many researchers to split oxysterols into two groups; those 
involved in cellular signaling necessary for normal cell function or oxysterols formed as 
metabolic products of cellular waste capable of cellular damage (15,22). Despite the number of 
reviews noting these two groups, this dichotomy is problematic as even many free-radical 
derived oxysterols are necessary for normal cellular processes and cannot be simply described as 
causative of adverse effects. The potential for individual oxysterol species to cause harm is better 
determined by examining the route of oxysterol formation (i.e. which oxidizing agent created 
them) and their concentration in a certain tissue. Thus, a more nuanced examination of oxysterols 
and a third category may be necessary.  
  For the purposes of this review we will divide oxysterols into three separate categories: 1) 
enzyme-induced, 2) free-radical-induced, and 3) environmentally-induced. Both enzyme-induced 
and free radical-induced occur naturally through normal cellular activity (Figure 1.3). In contrast, 
environmentally-induced oxysterols, are formed due to exogenous stressors and pose a unique 
challenge to cellular function and viability. Further, in each group we will discuss the biological 
systems influenced by the prominent oxysterol species formed and any potential for adverse 
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health effects. Through enumerating these divisions, we will examine the differences in 
formation, structure, and action of the species formed including their association with specific 
disease states. We pay particular attention to the third group of environmentally-induced 
oxysterols as they represent unique species with highly reactive electrophilic modifications to the 




1.2 Enzymatically Derived Oxysterols 
1.2.1 Enzyme Driven Oxysterol Formation 
The majority of normal oxysterols formed in the human body are a product of enzymatic 
conversion, driven primarily by CYP enzymes (23). Oxygenases such as CYPs serve to add an 
oxygen group onto cholesterol or its sterol precursors, forming oxysterols. After oxysterol 
formation, the addition of a single oxidation reaction reduces an oxysterol’s half-life and directs 
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the molecule to be degraded and excreted (24,25). Conversion of cholesterol into bile acids, 
steroid hormones, and signaling molecules, however, requires several oxidation steps and 
multiple enzymatic conversions (25). Enzymatically-derived oxysterols are strictly regulated and 
the more prominent species serve to maintain cholesterol homeostasis, waste removal, and cell 
developmental processes. Although some oxysterols are formed due to the action of a single 
enzyme, many are generated by the action of multiple enzymes. For example, the oxysterol 25-
hydroxycholesterol can be generated by CYP27A1, CYP46A1, or CYP3A4, making tracing its 
origin difficult (26). Here, we highlight the function of some of the more prominent oxysterol 
species formed due to enzymatic oxidation. 
Shown in Figure 1.4, the oxysterol 24,25-epoxycholesterol is a special case as it is 
formed by oxidation of a precursor sterol species formed early in the cholesterol synthesis 
pathway by CYP46A1. 24,25-epoxycholesterol can be formed in one of two ways: 1) as a de 
novo synthesis shunt of the normal cholesterol synthetic mevalonate pathway (27,28) or 2) 
7 
 
through enzymatic oxidation of desmosterol. In both cases 24,25-epoxycholesterol serves to 
suppress 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) activity and increase cholesterol 
transport gene expression, acting as a feedback defense mechanism to prevent excess synthesis 
of new cholesterol (29).  
In addition to regulation over cholesterol synthesis, a variety of metabolically formed 
oxysterols are responsible for regulation of total sterol content in both the cell and the human 
body. Cholesterol homeostasis signaling occurs primarily through the Liver X Receptor (LXR) 
transcription pathway. LXR, and its heterodimer the Retinoic X Receptor (RXR) are responsible 
for the expression of cholesterol efflux and binding proteins including ATP Binding Cassette 
Transporter Proteins A1 and G1 (ABCA1 and ABCG1), Fatty Acid Synthase B (FASB), and 
SREBP. A variety of CYP27A1 side chain modified oxysterols such as 22-R-hydroxycholesterol 
are capable of binding to the LXR/RXR heterodimer, signaling the activation of cholesterol 
transport and binding proteins mentioned above and shunting resources towards the conversion 




1.2.2 Oxysterol Synthesis in the Biliary System 
Oxysterol synthesis is of concern in the hepatobiliary system and governs the constituents 
and ratio of lipid content in bile acid for excretion (23,32,33). The major metabolic and rate 
limiting enzymatic reaction of biliary acid synthesis in humans starts with CYP7A1, cholesterol 
7α-hydroxylase, metabolism of cholesterol to form 7α-hydroxycholesterol (23,24,34-36). 
Alternatively, the oxysterol 27-hydroxycholesterol is formed through CYP27A1, 27-
hydroxylase, in the mitochondrial cytoplasm and functions with two cofactor proteins 
andrenodoxin and andrenodoxin reductase to hydroxylate a variety of sterols at the 27 position 
leading to the formation of cholestenoic acid (24). Current research indicates that other 
oxysterols such as 24S-hydroxycholesterol in the brain also contribute to bile acid synthesis and 
excretion and is discussed briefly in the following section. Overall the majority of studies 
indicate that oxysterol species involved in bile acid formation are exceptionally lipophilic and 
easily enter the biliary system as waste for excretion. 
 
1.2.3 Oxysterol Governed Cholesterol Homeostasis 
Principally, sterols and oxysterols act as sensor molecules, providing feedback regulation 
to govern total cholesterol content in the cell or whole tissue. Oxysterols exert posttranscriptional 
regulation of cholesterol homeostasis by controlling sterol transport throughout the cell and 
inhibiting de novo cholesterol synthesis as noted in Figure 1.4 (37). The oxysterol 25-
hydroxycholesterol mentioned above, promotes the degradation of 3-hydroxy-3-methylglutaryl-
CoA reductase (HMGCR), the rate-limiting enzyme in cholesterol synthesis by accelerating 
ubiquitination of HMGCR (38,39). Endoplasmic Reticulum (ER) transmembrane insulin induced 
proteins (Insig-1 and Insig-2) bind to 25-hydroxycholesterol, allowing for greater interaction 
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with the sterol regulatory element-binding protein (SREBP) cleavage-activating protein (SCAP), 
which allows for precise sterol sensing within the cell and inhibits further cholesterol synthesis 
and oxysterol formation (40,41). Cholesterol-derived oxysterol, 24,25-dihydrolanosterol, formed 
when CYP51 binds to Insig proteins, which in turn binds to the HMGCR, ubiquitinating the 
protein for proteasomal degradation and slowed cholesterol synthesis (15,42). 
 
1.2.4 Oxysterols in Neuronal Signaling 
As mentioned above, in addition to hepatobiliary excretion, oxysterols serve as potent 
signaling molecule and waste product in various tissues in the human body. The brain and central 
nervous system (CNS) contains some of the most lipid and cholesterol rich cells and metabolism 
of cholesterol is a key component of normal function and removal of waste products from the 
CNS infrastructure. The most abundant oxysterol in the brain, 24S-hyroxycholesterol is formed 
by metabolism of cholesterol by CYP46A1 (24-hydroxylase) in neuronal cells (43). 24S-
hydroxycholesterol readily passes through the blood brain barrier, activates reverse cholesterol 
transport signaling by activating LXR transcription pathway and increasing cholesterol efflux 
from cells in the CNS. Sterol waste product removal from the CNS and many tissues is very 
important in maintaining optimal cellular health and deficiencies in the process of enzyme-
derived oxysterol formation can be associated with the propagation of neurodegenerative 
disorders and other adverse human health conditions (44,45).  
 
1.2.5 Oxysterol Signaling and Immune Function 
Oxysterol control over the fundamental cellular processes discussed above applies to 
many systems governing human health and crucial attention must be paid to their involvement in 
10 
 
the context of immune cell development and immune response. Cholesterol research has pointed 
to a connection between optimum cholesterol homeostasis and host defense against pathogens 
and inflammation by regulating the cell membrane barrier integrity and decreasing waste 
generated oxidant stress (46). The oxysterol activation of LXR, discussed above and shown in 
Figure 1.5, has been repeatedly shown to also have a transrepressive effect on NF-kB pro-
inflammatory gene induction (47-49) and mitigates immune response to inflammatory stimuli. 
Studies have also determined that immune T-cell proliferation and activation is sterol dependent 
through LXR and cholesterol transport signaling (50,51). In addition to oxysterol feedback on 
cholesterol homeostasis governing immune cell proliferation, oxysterols can directly bind to 
immune receptors and alter immune response. The oxysterol 7α,25-dihydroxycholesterol has 
been shown to be a potent agonist for G protein coupled receptor 183 (GPR183), governing B 
cell maturation in the lymph nodes and T cell activity (52,53).  Moreover, a deficiency in 
CYP7B1 and decreased 7α,25-dihydroxycholesterol results in deficient T cell and B cell immune 
response (54). Furthermore, macrophage and dendritic cell migration, differentiation, and 
phagocytic capacity are impaired by cholesterol dysregulation and increased oxysterol 
concentrations (55,56).   
 
 
1.3 Free-Radical Induced Oxysterols 
1.3.1 Common Synthesis of Free-Radical Induced Oxysterols 
Nonenzymatic, or free-radical induced oxysterol formation occurs through cholesterol or 
precursor sterol species interaction with lipid peroxides, transition metal ions and reactive 
oxygen species (ROS) present throughout the human body (20). The random character of free 
radical oxidation and automated rearrangement of these reactive species confounds the exact 
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mechanism and route of formation for individual oxysterol species. Typically, oxidation of 
cholesterol resembles a lipid peroxidation reaction by abstracting the hydrogen from the C-7 
position, forming a radical carbon capable of further oxidation into cholesterol peroxyl radical 
and finally into relatively stable oxysterol species such as cholesterol hydroperoxide (Figure 1.1). 
The C-7 position is particularly susceptible to oxidation as the carbon-hydrogen bond has low 
dissociation energy and can be readily abstracted (57). Oxidation of cholesterol at the C-7 ring 
and formation of cholesterol hydroperoxide is short lived however, as it is further transformed 
into polar hydroxyl, keto, hydroperoxy, epoxy, or carboxyl moieties (58,59). Free-radical derived 
oxysterols such as these have unique interactions with normal cellular functions leading to 
adverse cellular events. 
 
1.3.2 Autoxidation and Mitochondrial Induced Free-Radical Oxysterol Signaling 
Free-radical formation through normal cellular activity is largely driven by mitochondrial 
respiration and the formation of ROS. The mitochondrial electron transport chain uses molecular 
oxygen molecules and creates superoxide anion radicals and subsequent breakdown products 
hydrogen peroxide and hydroxyl radicals. These reactive oxygen species (ROS) are involved in 
type 1 autoxidation of cholesterol and serve to typically modify the ring structure of cholesterol, 
forming some of the species mentioned above including 7β-hydroxy-cholesterol, 7-
ketocholesterol, and 5α,6α-epoxycholesterol (18). Cellular health influences ROS generation 
through normal cellular respiration.  The buildup of oxysterol autooxidation products can cause 
severe cytotoxic events in a cell. Excess 7-ketocholesterol and 27-hydroxycholesterol alter the 





1.4 Environmentally-Induced Oxysterols 
1.4.1 A New Classification: Exogenous Stressors and Oxysterol formation 
Despite the breadth of literature describing the mechanisms governing the metabolism 
and function of enzymatically-derived oxysterols, little focus has been given to environmentally-
induced oxysterols. Environmental stressors capable of forming oxysterols include pollutants, 
pathogens, and xenobiotics. Like all oxysterols, environmentally derived oxysterols are formed 
through an oxidation reaction with cholesterol or its precursors, however, the resulting species 
can be unique and exhibit a heightened capacity for electrophilic attack leading to cellular 
dysfunction and death. For this reason, we will highlight a few known environmental stressors 
involved in the formation of oxysterols including Ozone (O3). 
 
1.4.2 Ozone-derived Oxysterols 
The clearest example of environmentally-derived oxysterols are those formed due to 
ozonization. O3 induced oxidation of cholesterol is a special case as a specific exogenous 
pollutant is capable of forming oxysterols inside the human lung. O3 is a ubiquitous pollutant and 
80% of the global population is exposed to levels exceeding WHO guidelines throughout the 
year. Moreover, the target organ for O3 exposure, the lung, is lined with lipid rich surfactant 
made up of phospholipids, surfactant proteins and cholesterol. Cholesterol presents a prime 
target for ozonization, as it is the primary neutral lipid component of the airway lining fluid 
(64,65). It has been shown that the initial reaction of ozone with cholesterol yields 1,2,3-
trioxolane, which undergoes rapid and spontaneous decomposition to yield several additional 
reactive entities. These intermediary oxysterols ultimately undergo cleavage of the C-5 – C-6 
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double bond forming stable ozone-derived oxysterols such as 6-oxo-3,5-diol, 3,5,6-triol, α-
epoxycholesterol (EpChα), β-epoxycholesterol (EpChβ), Secosterol A (SecoA) and Secosterol B 
(SecoB) (66,67) (Figure 1.6). Studies examining electrophilic oxysterols, including our own, 
have shown the capacity for O3-derived oxysterols to form adducts with a variety of protein 
targets including those associated with cholesterol homeostasis and inflammatory signaling (68). 
The integrity of the airway epithelium is reliant on consistent cholesterol composition and 
concentration and even modest changes to the sterol profile of the airway could compromise the 
surface tension-reducing properties of surfactant and impact respiratory health (64). 
 
1.4.3 Pathogens, Infection and Oxysterol Formation 
In addition to oxysterols formed due to native free-radicals, foreign bodies and pathogens 
can serve to form additional reactive species and drive the formation of oxysterols. Chronic 
hepatitis C virus infection has been shown to enhance concentrations of certain oxysterols in the 
serum of patients (69). 7α-hydroxycholesterol, 4β-hydroxycholesterol, and 25-
hydroxycholesterol are all significantly elevated in individuals with chronic hepatitis C, 
suggesting that oxidative stress and inflammation caused by the infection influences systemic 
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sterol levels (70). It is unknown whether this change in oxysterol concentration is associated with 
propagating the disease state or merely a significant marker of the infection. Nevertheless, it is 
interesting to consider how exogenous stressors can impact oxysterol formation in the human 
body and should be considered when examining health effects and biomarkers of disease. 
 
1.4.4 Pharmaceutical Impact on Oxysterol Formation 
Pharmaceutical safety testing research has indicated that a growing list of commonly used 
drugs have the capacity to modify oxysterol formation either by desaturating cholesterol or 
altering overall sterol concentrations in the human body. Although many pharmaceuticals were 
designed to modify enzymatic activity or alter the availability of cholesterol, we believe this 
constitutes an exogenous stressor influencing oxysterol homeostasis and alters susceptibility to 
human disease. Statins, one of the most widely prescribed classes of drugs in the world, are 
designed to reduce systemic cholesterol available by inhibiting HMG-CoA reductase. Although 
it has not been clinically shown, epidemiologic evidence demonstrates that statins may protect 
against pollutant induced injury, an effect possibly mediated by cholesterol availability (71). 
Alternatively, other common drugs have the ability to increase oxysterol presence causing 
cellular dysfunction.  As an example, patients treated with antiepileptic drugs such as 
phenobarbital, carbamazepine or phenytoin exhibited 10-20 fold elevated levels of oxysterol 4β-
hydroxycholesterol (4β-HC) (72,73). The increase in 4β-HC may be due to a drug induced 
increase of CYP3A4 activity, however, the subsequent presence of 4β-HC found in 
atherosclerotic plaques compared to other prominent oxysterol species has not been fully 
explained (73). Additionally, the primary research discussed in Chapter 4 of this dissertation 
discusses the potential for small molecule antipsychotics and antidepressants such as 
15 
 
Aripiprazole (APZ) and Trazodone (TZD) to inhibit cholesterol synthesis steps and lead to 
oxidized precursor sterol molecules and uniquely reactive oxysterols. Considering that 
environmental exposure may coincide with pharmaceutical action on cholesterol availability, the 
potential for interaction and synergistic adverse effects is great. 
 
1.5 Disease States and Oxysterols 
1.5.1 Genetic Disorders affecting Oxysterol Synthesis 
Cholesterol precursor molecules are known to be even more prone to electrophilic attack 
than cholesterol itself and any genetic modifications to cholesterol synthesis could lead to 
increased oxysterol formation and detrimental health effects.  The genetic disorder known as 
Smith-Lemli-Opitz syndrome (SLOS) provides a unique look at the adverse impact altered sterol 
availability can have on human health. Individuals suffering from SLOS experience decreased 
overall cholesterol levels and an increase in the 7-DHC to cholesterol ratio, developmental and 
cognitive impairments, poor epithelial integrity and increased basal inflammatory signaling as a 
result of dysregulated cholesterol synthesis (74,75).  Genetic mutations of the 7-DHC reductase 
(DHCR7) gene are the hallmark of SLOS, which is characterized by high circulating levels of 7-
dehydrochlesterol (7-DHC) and low serum cholesterol (76). In individuals with SLOS, the final 
step in cholesterol synthesis, involving the conversion of 7-DHC to cholesterol by DHCR7, is 
disrupted. The resulting increased levels of 7-DHC, which has the highest rate constant for the 
propagation of free radical peroxidation of any lipid studied to date, would be very sensitive to 
oxidative damage (77). UV sensitivity is a hallmark of SLOS patients, exacerbating dermal 
inflammation and cell death, so it is possible that oxidant pollutants like O3 could have the same 
impact, especially in a cholesterol rich environment like the lung (78). 
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In addition to SLOS there are other disease states associated with dysregulation of 
oxysterols including dyslipidemia, atherosclerosis, and infection. Familial combined 
hyperlipidemia (FCH) is characterized by increased atherosclerotic lesions associated with 
oxidative damage to lipids circulating in the plasma (79). Oxidation of plasma cholesterol to 7-
keto and 7β-hydroxycholesterol is elevated in these patients and has been shown to be correlated 
with propagation of increased systemic inflammation leading to cardiovascular disease and 
atherosclerosis (80). 
Ancillary evidence has been presented regarding the role of oxysterols in 
neurodegenerative diseases. 24-hydrocholesterol is the principal oxysterol made by neuronal 
cells and is necessary for normal CNS function (81). Patients with Huntington’s disease, 
however, exhibit severely decreased levels of 24-hydrocholesterol (82,83). 24-hydrocholesterol 
is normally associated with initiating reverse cholesterol synthesis and waste removal from CNS 
tissues, any disruption of this process would result in accumulation of cellular waste products 
and a decrease in cellular viability commonly associated with Huntington’s Disease (43-45). 
Similar evidence has been presented regarding Alzheimer’s disease and tau protein occlusions, 
however, conclusive clinical evidence has yet to be presented (84,85).  Further, the use of 
dysregulated oxysterol formation and presence as a biomarker for neurodegenerative diseases, 
such as amyotrophic lateral sclerosis (ALS) has been proposed (86).  These examples show that 
cholesterol is an essential building block of the brain and a critical component of many 
biological functions, alteration of cholesterol synthesis or normal levels of oxysterols can result 




1.5.2 Oxysterols in Atherosclerosis 
The role of oxysterols in atherosclerosis is of particular interest as one of the first steps of 
plaque formation, macrophage conversion to foam cells, involves a high uptake of oxidized LDL 
and an indiscriminant uptake of other oxidized lipids (87,88). Although high levels of oxysterols 
have been associated with the development of atherosclerotic plaques and lesions, little 
conclusive evidence has been reported as to the route of formation of the oxysterols present and 
the mechanism driving atherosclerotic plaque development (89,90).  
Due to the associated progression of atherosclerosis most of the oxysterols present have 
been studied as a product of free-radical oxidation, however, their origin is not always clear. For 
example, elevated 27-hydroxycholesterol has been shown to promote atherosclerosis by altering 
sterol uptake in human macrophages and mouse atherosclerotic lesions, but little information is 
available as to why there is such an increase in 27-hydroxycholesterol availability and why build 
up in macrophages induced plaques (91,92).  
In addition to free-radical induced oxysterols, 7a- and 7B-OH-Ch 5,6-epoxycholesterol, 
7-oxo-cholesterol and Secosterols A and B all have been recorded at higher than normal 
concentrations in atherosclerotic lesions, but their source has not been elucidated.  Interestingly, 
Secosterols A and B are thought to be exclusively oxysterol products specific to oxidation by 
ambient O3, making their presence in atherosclerotic plaques cells perplexing (93). One report 
indicates that their presence in foam cells could be due to substantial flux of oxysterols through 
the airway and into circulation (94). The abnormal accumulation of macrophages in the lung 
during dyslipidemic events could be driving the oxysterol efflux out of the airway, however, 
current measurement techniques cannot identify oxysterol origin with complete certainty (95). 
The field of atherosclerosis could be well served by early and accurate analysis of the oxysterol 
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species and concentrations found in early macrophage foam cells and plaques as it is still unclear 
whether reactive oxysterols have a causal role in atherogenesis.  
 
1.6 Scope and Impact: Oxysterols in the Human Airway 
Through varied function and formation in the human body, oxysterols have positioned 
themselves as a target of interest in biomedical and biochemical research. Under normal 
conditions, oxysterols are key to cellular function across the human body, thus any perturbation 
to their formation could be a cause for concern. In this review, we considered oxysterol 
formation through enzymatic and free-radical means, with the latter category split into those 
formed endogenously and those formed through external stressors. When examining those 
oxysterols formed due to genetic disorder, environmental stressors, drugs, and infection, there is 
overwhelmingly compelling evidence to explore oxysterols as both potential causative factors 
and biomarkers of disease states. The focus of our research lies in pollutant-induced 
inflammation and immune response and our primary research papers serve to uncover how the 
pollutant O3 impacts oxysterol formation in the lung impacts those adverse events.  
 
1.6.1 Airway Lining Fluid as a Target for Ozonization 
The airway surface liquid (ASL) and airway epithelial cell membranes are rich in 
cholesterol and other lipid components, which can be directly targeted for oxidation by O3 
(96,97). As Figure 1.7 depicts, the ASL is mostly comprised of phospholipids with smaller 
contributions of surfactant proteins and cholesterol.  Previous studies have demonstrated that the 
formation of lipid ozonization products (LOPs) can mimic many of the adverse health effects 
observed after exposure to O3, however, the involvement of cholesterol ozonization products has 
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not been fully examined (98-100). Cholesterol makes up approximately 10% of the mass of 
human pulmonary surfactant but is 80-90% of the neutral lipid fraction (64,101).  Ozonolysis of 
cholesterol differs from other phospoholipids located in the ASL, as O3-derived oxysterols are 
formed into aldehyde and ketone electrophiles and LOPs undergo free radical chain initiation 
and lipid peroxidation chain propagation (98). Previous O3 exposure studies utilizing human 
pulmonary surfactant and bronchoalveolar lavage fluid exposed to O3, as well as tissue from 
exposed mice and rats, show the cholesterol 5,6-double bond and concomitant vinylic methylene 
group moieties of cholesterol are particularly susceptible to oxidation, resulting in the formation 
of oxysterols (66,67,102-104). Ozonization of the ASL creates unique and highly reactive 
oxysterol species such as SecoA and SecoB which have heightened biochemical potential to 




1.6.2 Oxysterol Potential for Protein Adduction 
Numerous in vitro and in vivo studies have demonstrated that exposure to O3 causes rapid 
activation of the NF-κB signaling pathway, generation of pro-inflammatory mediators, and 
infiltration of neutrophils into the airways. Yet, mechanisms linking the known chemical 
reactivity of O3 and its reaction products with biological effects continue to present a knowledge 
gap. A series of studies suggest that ozonized phospholipids could recapitulate O3-induced 
activation of NF-κB and pro-inflammatory mediator production (99,100). Similarly, 4-
hydroxynonenal (4-HNE), formed during phospholipid peroxidation, causes covalent 
modification of proteins and also mimics O3-induced biological effects (105,106). Further, our 
collaborator Dr. Ned Porter and his group has discovered that O3-derived electrophilic oxysterols 
react with nucleophilic centers of proteins (largely lysine residues), forming oxysterol-protein 
adducts, which could affect the function of these proteins (93), thus providing a new paradigm 
linking O3-induced chemical modification of lipids with changes in protein function. While a 
number of studies, including our own, demonstrate modification of specific proteins with 
cholesterol ozonolysis products (68,93,107,108), much remains to be learned about the identity 
of the reactive species, the range of potential proteins modified by these oxysterols in the lung, 
and the associated biological consequences. 
 Studies in various cell types have shown that O3-derived oxysterol species readily 
react with the nucleophilic lysine, cysteine, and histidine residues of proteins to form covalent 
linkages (109-112). Specifically, the aldehyde moiety of secosterols has an affinity for adduction 
to nucleophilic lysine residues in a number of proteins (113). The covalent adduction is 
characterized by a secure N=C linkage. This strong covalent modification makes the protein 
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more hydrophobic and is capable of inhibiting a protein’s localization and/or altering its normal 
function (114). 
 
1.6.3 Drug-x-Environment Interaction: Impact on Oxysterol Synthesis 
Previous studies have shown drug x pollutant interaction involving cholesterol 
modification and air pollutants. Statins, a known cholesterol modulator drug, have been shown to 
protect against particulate matter air pollution induced inflammation; however, the mechanism of 
interaction is not fully understood (71,115,116). Additionally, some data exist indicating that 
Acetaminophen treatment has the potential to interact with O3 exposure, exacerbating drug 
induced liver injury in mice (117). Both of these examples highlight the impact pollutants and 
pharmaceuticals alone can have on oxysterol formation and associated cellular functions. Thus, 
there is potential that a synergistic effect between O3 and cholesterol modulating drugs could 
have a heightened impact on sterol formation and inflammation. Because of the potential link 
between lipid metabolism and pollutant-induced inflammation, foods or drugs known to reduce 
systemic cholesterol levels have been explored for attenuating pollutant or O3-induced adverse 
health effects (118-121). Despite these studies, little data has been recorded examining drug x 
pollutant interaction and respiratory inflammation. Since circulating plasma lipoproteins present 
the major source of lipids in the lung, dietary contributions and overall systemic lipid 
metabolism status are likely the predominant factors determining lung cholesterol levels (122). 
Our primary research discussed in chapter 4 goes further by determining if commonly prescribed 
drugs that modify sterol levels like APZ can potentiate the already well described oxysterol 




1.6.4 Specific Aims of this Study and Overall Impact 
O3 is a global air pollutant that causes adverse health outcomes, such as decreased lung 
function, increased airway inflammation, and exacerbating pre-existing diseases such as asthma. 
Although the inflammatory response and adverse health effects of O3 exposure have been 
characterized, the underlying biochemical and cellular mechanisms by which O3 mediates 
adverse health effects and inflammation remain poorly understood. I hypothesize that one 
mechanism by which O3 may induce adverse health effects is via oxysterol formation in the 
airway.  O3-derived oxysterols are electrophilic compounds capable of reacting with nucleophilic 
residues and forming lipid-protein adducts on a wide variety of protein species. Further, studying 
mechanisms associated with O3-derived oxysterol induced health effects can provide a basis to 
understand susceptibility factors and potential therapeutic interventions. Thus, my studies 
examining how O3-derivied oxysterols affect inflammatory pathways may uncover mechanisms 
by which these drugs modify respiratory responses to O3.  
Therefore, my general hypothesis is that O3-derived oxysterols adduct to cellular 
proteins, activating pro inflammatory signaling cascades and that these responses can be 
modified by cholesterol-altering drugs, such as small molecule antipsychotic drugs. The 
following specific aims are intended to test my central hypothesis: (SA1) Identify oxysterol 
species formed following O3 exposure and determine their potential to adduct to protein targets. 
My preliminary results describe a variety of oxidized cholesterol species in the bronchoalveolar 
lavage fluid from human volunteers exposed to O3 in vivo and epithelial cells exposed to O3 in 
vitro. My data also demonstrate lipid-protein adduction between specific oxysterols and cellular 
proteins. I expand these initial observations and assess the “adductome” using “click” 
cycloaddition followed by proteomics analysis, addressed in chapter 3. (SA2) Characterize the 
mechanisms by which O3-derived oxysterols impact cellular response. To determine if O3-
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derived oxysterols are capable of inducing inflammation in airway epithelial cells by adducting 
to specific signaling molecules, we examine oxysterol-protein adduction of specific NF-κB 
inflammation and inflammasome activation pathway proteins, addressed in chapter 3. (SA3) 
Determine if cholesterol-modifying drugs, such as small molecule antidepressants, modulate O3-
induced inflammation. For example, small molecule antidepressant drugs (e.g. aripiprazole, 
trazodone) are known to increase overall cholesterol load, yet whether these drugs sensitize 
individuals to O3-induced adverse health effects is unknown.  We investigate how these drugs 
modify O3-induced oxysterol formation and enhanced inflammatory signaling in airway 
epithelial cells, informing future in vivo and clinical studies, addressed in chapter 4.  
The guiding hypothesis of this research is that exposure of the airways to O3 generates 
oxysterols at or near the epithelial surface that adduct to cellular proteins to modify cellular 
signaling and increase airway inflammation. Using the findings developed in this study, we 
uncover novel interactions between oxidized lipids and cell function in settings of oxidant 
exposures with relevance beyond O3. Additionally, our findings foster a better understanding of 
the potential for pharmaceutical drugs to interact with environmental oxidant exposures. 
Observations gained from my studies will provide the basis for subsequent human in vivo studies 
determining the interaction between cholesterol-modifying drugs and pollutant-induced lung 
inflammation, thus uncovering potential drug-pollutant interactions, which can modulate the risk 
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CHAPTER 2. – OZONE-DERIVED OXYSTEROLS AFFECT LIVER X RECEPTOR 
(LXR) SIGNALING: A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS. 
2.1 Overview 
When inhaled, ozone (O3) interacts with cholesterols of airway epithelial cell membranes 
or the lung lining fluid, generating chemically reactive oxysterols. The mechanism by which O3-
derived oxysterols affect molecular function is unknown. Our data show that in vitro exposure of 
human bronchial epithelial cells to O3 results in the formation of oxysterols, epoxycholesterol-α 
and β (α-EpCh, β-EpCh) and Secosterol A and B (Seco A, SecoB), in cell lysates and apical 
washes. Similarly, bronchoalveolar lavage fluid obtained from human volunteers exposed to O3 
contained elevated levels of these oxysterol species. As expected, O3-derived oxysterols have a 
pro-inflammatory effect and increase NF-B activity. Interestingly, expression of the cholesterol 
efflux pump ATP-binding cassette transporter 1 (ABCA1), which is regulated by activation of 
the liver X receptor (LXR), was suppressed in epithelial cells exposed to O3. Additionally, 
exposure of LXR knockout mice to O3 enhanced pro-inflammatory cytokine production in the 
lung, suggesting LXR inhibits O3-induced inflammation. Using alkynyl surrogates of O3-derived 
oxysterols, our data demonstrate adduction of LXR with Seco A. Similarly, supplementation of 
epithelial cells with alkynyl-tagged cholesterol followed by O3 exposure causes observable lipid-
LXR adduct formation. Experiments using Seco A and the LXR agonist T0901317 (T09) showed 
reduced expression of ABCA1 as compared to stimulation with T09 alone, indicating that Seco 
A-LXR protein adduct formation inhibits LXR activation by traditional agonists. Overall, these 
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data demonstrate that O3-derived oxysterols have pro-inflammatory functions and form lipid-
protein adducts with LXR, thus leading to suppressed cholesterol regulatory gene expression and 
providing a biochemical mechanism mediating O3-derived formation of oxidized lipids in the 
airways and subsequent adverse health effects. 
2.2 Introduction 
Currently, the oxidant gas ozone (O3) is the most widespread air pollutant found in the 
U.S. and contributes to a growing variety of adverse health outcomes (1). O3 exposure causes 
decreased lung function and increased airway inflammation, which exacerbates pre-existing 
diseases such as asthma and may contribute to certain cardiovascular diseases, all potentially 
increasing the risk of premature death (2). Although the inflammatory response and adverse 
health effects of O3 exposure have been documented for decades, the biochemical and cellular 
mechanisms by which O3 mediates adverse health effects remain poorly understood. As a very 
potent oxidant gas, O3 reacts readily with the surface components of the airway and causes 
cellular modification through reactions with the airway lining fluid and epithelial cellular 
membranes (2-4). The lung lining fluid and epithelial cell membranes are rich in cholesterol and 
other lipids, which can be directly oxidized by O3 (5, 6). Previous studies have determined the 
impact ozonization of lipids, particularly poly unsaturated fatty acids (PUFA), may have on O3 
associated toxic effects. These studies demonstrated that ozonization of PUFAs and the 
formation of lipid ozonization products (LOPs) can mimic many of the adverse health effects 
observed after exposure to O3 (5, 7-9). However, the involvement of cholesterol ozonization 
products requires further study. The cholesterol 5,6-double bond and concomitant vinylic 
methylene group moieties are particularly susceptible to oxidation, resulting in the formation of 
oxysterols (5, 10-12). 
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Many oxysterols are electrophiles capable of reacting with nucleophilic residues on 
proteins and other biological macromolecules. They are formed endogenously through enzymatic 
and non-enzymatic reactions.  P450 cytochrome enzymes metabolize endogenous cholesterol 
into oxysterol species such as 27-hydroxycholesterol, an essential oxysterol for cellular 
cholesterol homeostasis (13). Studies show that endogenous oxysterols can act as both agonists 
and antagonists for transcription factors such as the liver X receptor (LXR). Within the LXR 
protein, a ligand binding domain has been characterized and shown to bind to synthesized 
oxysterol species in vitro, which is the same region that is the target for various post translational 
modifications such as acetylation and SUMOylation (14). LXR regulates the synthesis of 
cholesterol transport proteins, such as ATP-binding cassette transporter A1 (ABCA1). ABCA1 
transports cholesterol across the cell membrane and shuttles it onto apolipoproteins, resulting in 
the formation of high-density lipoproteins (HDL). Systemically, failure to produce adequate 
ABCA1 reduces the ability to generate and transport HDL and is associated with early onset 
cardiovascular disease, supporting the protective role of ABCA1 in cholesterol metabolism and 
atherosclerosis (15). In addition to lipid metabolism, both LXR and ABCA1 have been 
implicated in anti-inflammatory functions (16-19). Moreover, exogenously derived oxysterols 
can cause adverse cellular effects and have been shown to modulate host immune cell and 
inflammatory responses (20-22). Oxidation of endogenous cholesterols by various reactive 
oxygen species (ROS) results in the formation of oxysterols associated with various pathologic 
processes driven through interaction with the nucleophilic domains of key proteins (23). 
Elevated levels of specific oxysterol species have been linked to a variety of adverse biological 
activities including cytotoxicity, increased inflammation, and amplified infection (24-26).  
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Rodent exposure studies and in vitro studies using human pulmonary surfactant have 
demonstrated the formation of O3-derived oxidized cholesterol products in various chemical 
compositions (5, 6, 10, 27, 28). Figure 2.1 depicts the primary reactive O3-derived oxysterol 
products Secosterol A (Seco A) along with its aldol condensation product Secosterol B (Seco B), 
and epoxycholesterols α and β (α-EpCh, β-EpCh) (11, 29). Some of these O3-derived oxysterols 
have been found in atherosclerotic tissue and cause foam cell formation, a hallmark of plaque 
buildup (26). Despite increased interest in the role of oxysterols in human health, especially 
cardiovascular diseases, information about O3-derived oxysterols in the airway, their cellular 
targets, and their biochemical interactions are very limited.  
 We hypothesize that exposure to O3 generates lipid-derived electrophiles in the 
human airway, including reactive species of oxysterols, at or near the epithelial surface that can 
adduct to cellular proteins, thus ultimately affecting cellular function and inflammatory response. 
Our study is designed to uncover electrophilic interactions between O3-derived oxysterols and 
proteins as a new mechanistic paradigm mediating adverse health effects induced upon 
inhalation of O3. 
 
2.3 Materials and Methods 
Reagents - Alkynyl-probes were synthesized following the procedures published 
elsewhere (29, 32). DTT and iodoacetamide were purchased from Sigma Aldrich (St Louise, 
MO).  Streptavidin beads were purchased from GE Healthcare (Piscataway, NJ). The following 
reagents were purchased from their respective companies: 10% NuPage Novex Bis-Tris® precast 
mini gel (Invitrogen, Grand Island, NY), PVDF membrane and Simply Blue (Bio Rad, Hercules, 
CA), IRDye®  800CW Streptavidin (925-32230, Li-Cor, Lincoln, NE), Blocking buffer 
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(Rockland, Gillbertsville, PA or Odyssey Blocking buffer, Li-Cor, NE). Sequencing grade 
Trypsin (Promega V5111, Madison, WI). Antibodies of HSP90, LXR-β, PPAR-γ, and Actin 
were from Santa Cruz (Dallas, Texas) and, LXR-α was purchased from Abcam® (Cambridge, 
MA).  
Cell Culture - 16HBE14o (16HBE) cells, a SV-40 transformed human bronchial 
epithelial cell line were a gift from Dr. D. C. Gruenert (University of California San Francisco, 
San Francisco, CA). 16HBE cells were plated on fibronectin-coated (LHC Basal Medium [Life 
Technologies, Carlsbad, CA], 0.01% BSA [Sigma, St. Louis, MO], 1% Vitricol [Advanced Bio 
Matrix, San Diego, CA], and 1% human fibronectin  [BD Biosciences, San Jose, CA]) 0.4µm 
Transwell® plates(Costar, Corning, NY), and grown submerged in minimal essential media 
(Gibco) with 10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine (Life Technologies) 
until confluent for 6 days, and 1 day at air-liquid interface (ALI) before use. Primary human 
bronchial epithelial cells (HBEC) were obtained from healthy donors in collaboration with the 
Environmental Protection Agency (EPA) using a protocol approved by the University of North 
Carolina at Chapel Hill Institutional Review Board (Chapel Hill, NC), as described previously 
(66) The HBECs were cultured in Pneumocult medium for 21 days to differentiate according to 
previously described methods (67, 68).  
In Vitro O3 Exposure - Cultures at ALI were exposed to filtered air or 0.4ppm O3 for 4 
hours in exposure chambers operated by the U.S. EPA, as previously described (69). The dose 
was selected for maximal innate immune response to O3 with minimal cytotoxicity and has been 




min, and were stored at -80 °C until LC-MS analysis.  
In Vivo Exposure of Healthy Volunteers to O3 - Written informed consent was provided 
by each participant. Healthy volunteers were randomly exposed to air and (in a separate 
exposure) 0.3 ppm O3 for 2 h with exercise, with a minimum 2-week separation between 
exposures in collaboration with the U.S. EPA using a protocol approved by the University of 
North Carolina Chapel Hill Institutional Review Board, as described previously(70). 
Bronchoscopy was performed 1 and 24 h after exposure. Cell-free bronchoalveolar lavage fluid 
(BALF) was stored at -80oC pending analysis (30).  
Real-time qPCR - Total RNA was isolated from 16HBEs and HBECs with the use of the 
Pure Link RNA Mini Kit (Life Technologies, Carlsbad, CA). First strand cDNA preparation and 
real-time quantitative PCR (qPCR) were performed as previously described (71, 72). Primers and 
probes for ABCA1, ABCG1, FASN, SREBP1, and β-actin were commercially available (Applied 
Biosystems, Foster City, CA). Human IL8: 5’-FAM-CCTTGGCAAAACTGCACCTTCAC-
TAMRA-3’ (probe), 5’-TTGGCAGCCTTCCTGATTTC-3’ (sense), and 5’-
TATGCACTGACATCTAAGTTCTTTAGCA-3’ (antisense) and IL6: 5’-FAM-
CCAGCATCAGTCCCAAGAAGGCAACT-TAMRA-3’ (probe), 5’-
TATGAAGTTCCTCTCTGCAAGAGA-3’ (sense), and 5’-TAGGGAAGGCCGTGGTT-3’ 
(antisense) were prepared in-house.  Differences in expression were determined with the ΔΔCt 
method and β-actin for normalization. Briefly, threshold cycle (Ct) value for the housekeeping 
gene (β-actin
value. For each pairwise set of samples to be compared, the difference in ΔCt values between the 
two samples were calculated for the genes of interest to determine the ΔCt value. The fold 
change in gene expression was calculated as 2-ΔΔCt. 
41 
 
Sterol profiling using PTAD derivatization and LC-SRM Analysis. Cells were scraped 
into 4 µL were taken and internal standards added (13 ng for d7-
7-DHC, 97 ng for 13C3-Desmosterol and 99 ng for 
13C3-Lanosterol, and 342 ng for d7-
Cholesterol/sample), 10 µL butylated hydroxytoluene (BHT)/triphenylphosphine (TPP) solution 
(2.5 mg TPP and 1 mg BHT in 1 mL MeOH), 400 µL 1% NaCl, and 500 µL Folch solution 
(2:1=CHCl3:MeOH).  Cells and standards were vortexed vigorously and centrifuged at 3099 x g 
for 5 min. CHCl3 layer was removed and added to PTAD-predeposited tube (200 µg/tube). The 
sample tubes were vortexed and analyzed by LC-MS using the following conditions: 10 µL was 
injected onto the column (Acquity UPLC BEH C18, 1.7 µm, 2.1 x 50 mm) with 100% MeOH 
(0.1% acetic acid) mobile phase for 1 min runtime at a flow rate of 300 µL/min. The monitored 
transitions included: 7-DHC m/z 560365, d7-7-DHC m/z 567372, desmosterol m/z 
592365, 13C3-desmosterol m/z 595368, lanosterol m/z 634602, 
13C3-lanosterol m/z 
637605 with retention times of 0.8, 0.5, and 0.6 min, respectively. 
Oxysterol Extraction from 16HBE or HBEC cells. - To the cell pellets, 10 µL alkynyl-
Cholesterol (a-Chol) (25ng/µL), 500 µL NaCl (0.9%), 10 µL of TPP and BHT (25 mg TPP and 
10 mg BHT in 10 mL MeOH), 1 mL of Folch solution (2:1=CHCl3:MeOH) were added. The 
mixture was mixed vigorously by vortex for 2 min and separated by centrifugation with 2300 x g 
for 3 min. The collected organic layer (bottom layer) was evaporated to dryness in a SpeedVac™ 
concentrator and resuspended in 100 µL MeOH for LC-MS analysis. 
Oxysterol Extraction from Cell-free Bronchoalveolar Lavage Fluid (BALF). - To 1 mL 
-Seco B (a-Seco B) (50 ng/µL), 1mL NaCl (0.9%), 10 µL of TPP and 
BHT (25 mg TPP and 10 mg BHT in 10 mL MeOH), 2 mL of MeOH, and 3 mL of iso-octane 
were added. The mixture was vortexed vigorously for 2 min and separated by centrifugation. The 
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collected organic layer was evaporated to dryness in a SpeedVac™ concentrator and 
resuspended in 100 µL MeOH for LC-MS analysis. 
LC-MS Analysis - The resuspended samples were chromatographed by RP-HPLC using a 
UPLC BEH C18 column (1.7 μm, 2.1 mm × 100 mm) in Waters Acquity UPLC system equipped 
with an autosampler (Waters, Milford, MA) and either ESI or APCI in positive ion mode. For 
ESI, the oxysterols were separated by 95% solvent B in an isocratic method with a flow rate of 
4OAc (solvent A) in water 
and 2 mM NH4OAc in MeOH (solvent B). The injection volume was 10 μL using a partial loop 
with needle overfill mode. MS detections were done using a TSQ Quantum Ultra tandem mass 
spectrometer (ThermoFisher, Waltham, MA), and data was acquired and analyzed using a 
Thermo Xcalibur™ 2.2 software package. The cholesterol and oxysterols form [M+NH4]
+ ions 
in positive ion mode (10). The transitions monitored were m/z 436383 for Seco A/B, m/z 
418365 for a-Seco A/B, m/z 404369 for cholesterol (Chol), m/z 386351 for a-Chol, m/z 
420385 for EpCh, m/z 402367 for a-EpCh. For APCI, 95% MeOH in H2O containing 0.01% 
acetic acid was used as a mobile phase. The cholesterol and oxysterols form [M+H]+ ions in 
positive ion mode. The transitions were m/z 369369 for Chol, m/z 383383 for Seco A/B, m/z 
351351 for a-Chol, m/z 385385 for EpCh. The transitions of cholesterol and cholesterol 
esters were m/z 365  365 monitored by HPLC-MS following the method described elsewhere 
(73). The amount of the cholesterol esters were found to be less than 2% of free cholesterol in 
the cells studied. 
Cytokine Analysis: Concentration of IL-6 and IL-8 in the apical wash of 16HBE cells 
exposed to O3 was determined by enzyme-linked immunosorbent assay (ELISA) according to the 
manufacturer instructions (BD Biosciences, San Jose, CA).  
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Western Blotting: Cell lysates from 16HBE cells exposed to air/O3 or O3 derived 
oxysterols were separated by 10% SDS-PAGE and transferred to nitrocellulose. Proteins were 
detected using specific antibodies (Santa Cruz, Dallas TX) to ABCA1 (1:500) or β-actin (1-
2000), which served s a loading control. Antigen-antibody complexes were incubated with 
horseradish peroxidase-conjugated secondary antibody and were detected using 
chemiluminescence.  
Murine Whole Body O3 Exposure, BAL, Cytokine and RNA Analysis: C57BL/6J (WT) 
female mice, 8-12 weeks old and weighing 15-20g, were purchased from Jackson Laboratories 
(Bar Harbor, ME).  LXRα-/- female mice, 8-12 weeks old and weighing 15-20g, originally a kind 
gift from Dr. David Mangelsdorf, were bred in-house and backcrossed >8 generations onto a 
C57BL/6 background before use. All experiments were performed in accordance with the 
Animal Welfare Act and the U.S. Public Health Service Policy on Humane Care and Use of 
Laboratory Animals after review by the Animal Care and Use Committee of the National 
Institute of Environmental Health Sciences.  Mice were placed in stainless steel wire exposure 
chambers inside a plexiglass chamber and exposed to filtered air or O3 for 3 h at a dose of 2 ppm. 
O3 was generated by directing 100% oxygen through an ultraviolet light generator and mixed 
with a humidified air supply to the chamber. Temperature and humidity of chamber air are 
monitored continuously, as was the O3 concentration with a Teledyne T400 ultraviolet light 
photometer. BALF was collected immediately following sacrifice and cell counts performed as 
described previously (74). Protein analysis was performed using BCA Protein Assay (Pierce, 
Rockfort, IL.) Cytokine analysis was performed using a Bioplex assay for IL-6 on the BALF 
(Bio-Rad, Hercules, CA). After necropsy, lung tissue samples were snap frozen in liquid 
nitrogen and stored at -80°C until RNA isolation. RNA was extracted and cDNA transcribed 
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(Applied Biosystems, Foster City, CA). 50ng of cDNA was used for qPCR for IL-6 
(Mm00446190_m1; Applied Biosystems) and endogenous 18S (4319413) (Applied Biosystems). 
Ct values were determined using ABI 7500 Real Time PCR System with SDS software 1.3.1. 
Change in expression was calculated using the 2-ΔΔCt method normalized to 18S expression and 
expressed as fold-change compared to the control group. 
Cell Culture and Whole Cell Labeling with a-Seco A in 16HBE - 16HBE cells were 
plated 2 x 106 in 10 cm plates using the conditions described above, then allowed to settle and 
grow for 24 h. The cells were then incubated in the presence of a-Seco A (20 μM) in reduced 
FBS (2%) MEM medium for 4 h. Cells were harvested in lysis buffer (50 mM HEPES, 150 mM 
NaCl, 0.1% TritonX100, pH=7.0) containing protease inhibitors (Sigma P8340) on ice. The 
lysate was cleared by centrifugation at 10,000 x g for 10 min @ 4 °C to remove cellular debris.  
The total protein concentration was determined using standard BCA assay (Pierce, 
ThermoFisher) for further click reaction. 
Cell Culture and Whole Cell Labeling with a-Cholesterol Followed by Ozone Exposure 
in Human Bronchial Epithelial Cells (16HBE) - 16HBE cells were grown in 24 mm transwells 
submerged in MEM with reduced FBS containing 20μM a-Chol for 6 days. The apical media 
was removed 24 h before exposure. Next, the plate was exposed to filtered air or O3 (0.4 ppm) 
for 4 h and allowed to continue for an additional 1 h incubation without O3 (1 h post incubation). 
Cells were harvested in 300 µL lysis buffer/well on ice and all wells were then combined for 
each condition. The lysate was cleared by centrifugation at 10,000 x g for 10 min @ 4 °C to 
remove cellular debris.  The total protein concentration was determined using standard BCA 
assay (Pierce, ThermoFisher) for further click reaction. 
Click Biotinylation of a-Seco A/a-oxysterols Adducted Proteins in 16HBE and 
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Streptavidin Affinity Purification - 1mL of cell lysates (2 mg/mL) were reduced with sodium 
borohydride, 5 mM final concentration, for 1 h on ice to stabilize the adducts. Excess sodium 
borohydride was deactivated by acidification of the mixture by adding 1M HCl. Subsequently, 
all click reagents were added to the reduced cell lysates, including the photo-cleavable azido-
biotin (39) (0.2 mM final concentration, tris(3-hydroxypropyltriazoylmethyl)amine (THPTA) 
(75) (0.2 mM), CuSO4 (1 mM), and sodium ascorbate (1 mM), and the reaction mixture was 
vortexed and allowed to react at room temperature for 1 h. 50 µL of the reaction mixture was 
saved for Streptavidin visualization. The rest was precipitated using cold methanol (3/1 = 
MeOH/H2O, v/v) to remove excess biotin linker. The precipitated protein pellets were 
reconstituted in 1 mL of 0.1% SDS in PBS including 200 µL of streptavidin (GE Health 
Bioscience) slurry. The slurry was rotated in the dark for 2h at room temperature to capture the 
adducted proteins. After 2 h, the tube was spun at 95 x g for 1 min and the supernatant removed 
(flow-through). The beads were then washed with 1 mL of 1% SDS (x2), 4M urea (x2), 1M 
NaCl (x2), and 25 mM ammonium bicarbonate (AMBIC, x2) respectively. The slurry was 
transferred to a 0.2 µm cellulose acetate spin filter (Costar) in 500 µL of 25 mM AMBIC and 
spun at 95 x g for 1 min. The slurry was re-suspended with AMBIC and photolyzed under hand-
held UV light (365 nm) for 2 h with gentle stirring at room temperature. The spin filter was spun 
at 95 x g for 1 min to recover photo-released proteins. The beads were washed twice with 500 µL 
of 25 mM AMBIC and the combined filtrates were evaporated to dryness in a SpeedVac™ 
concentrator.  
Visualization of Biotinylated Proteins Adducted with a-SecoA/a-Oxysterols - The saved 
50 µL of click-reaction mixture was mixed with SDS sample loading buffer and resolved using 
10% NuPAGE Novex BisTris® gel (Invitrogen, Carlsbad, CA). The proteins were 
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electrophoretically transferred to a polyvinylidene difluoride (PVDF) membrane (BioRad, 
Hercules CA) and probed with IRDye® 800CW Streptavidin (Li-Cor, Lincoln, NE). The extent 
of adduction was visualized using Odyssey Infrared Imaging System™. 
Immunoblotting Analysis of Photo-released Proteins - The photo-released and dried 
proteins were reconstituted in 70 µL PBS L of 1M DTT and resolved 
by 10 % NuPAGE Novex BisTris® gel then transferred to PVDF membrane. The transferred 
proteins were incubated with antibodies of HSP90 (anti-rabbit, Santa Cruz), LXR-α (anti-rabbit, 
Abcam®), LXR-β, (anti-rabbit, Santa Cruz) or PPAR-γ (anti-mouse, Santa Cruz) (1:1000) 
overnight in the cold room at 4oC. Alexa Fluor 680® labeled secondary anti-rabbit or mouse was 
used to detect target proteins. Immunoreactive proteins were visualized using Odyssey Infrared 
Imaging System™ (Li-Cor, Lincoln, NE). 
Modification of Gene Expression by Sequential Seco A - T09 Challenges - 16HBE cells 
were grown submerged in MEM medium and repeatedly challenged with 20µM Seco A, 10µM 
T09 or DMSO in a crossover design. Briefly, cells were challenged with the first stimulus for 2 
h, washed with HBSS, and challenged again with either 20µM Seco A, 10μM T09 or DMSO for 
2 h. The cells were washed again with HBSS and RNA was collected for analysis as described 
above.  
NF-κB and LXRE Promoter Reporter Activity in 16HBE Cells - 16HBE cells were 
transduced with NF-κB-luciferase lentiviral vector at a multiplicity of infection of 5 and were 
cultured for seven days (76). To select for transduced cells, the cells were cultured with 
hygromycin for nine days to create a stable cell line, which was used for subsequent reporter 
assays. To assess NF-κB activation, stably transduced 16HBE cells were plated overnight and 
then treated with α-EpCh, β-EpCh, Seco A, SecoB (all 20 µM) or TNF-α (20 ng/mL, 
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Calbiochem, Billerica, MA) for 4 and 24 h. For the LXR response elements (LXRE) promoter 
activity measurement, LXRE-luciferase vector (System Biosciences Inc, San Francisco, CA) was 
transiently transfected into 16HBE cells and allowed to expand for at least 1 day. The cells were 
then exposed to individual oxysterols or used in the sequential challenge with Seco A and T09 as 
described above. Cell lysates were harvested and subjected to dual luciferase assay (Promega, 
Madison, WI). Data were normalized to total protein levels and expressed as relative luciferase 
units (RLU). 
Statistical Analysis – All in vitro data were performed in at least 3 separate experiments. 
Data shown are mean ±SEM and significance indicated as p<0.05. See figure legends and for 
further information on the specific statistical analysis used for each experiment. 
 
2.4 Results 
Identification of O3 induced Oxysterol Formation in vitro and in vivo – Primary 
differentiated HBEC cells and 16HBE cells were chosen to evaluate the presence of oxysterol 
species in vitro following exposure to O3. Representative HPLC-MS profiles reflected increased 
levels of oxysterol species in O3 exposed 16HBE cells (Fig. 2.2A) compared to filtered air-
exposed cells. 16HBE cells exposed to O3 exhibited elevated concentrations of α-EpCh, β-EpCh, 
and Seco B in cell lysates (Fig. 2.2B) and in the apical washes (Fig. 2.2C) collected both 1 and 
24 h post-exposure compared to the air exposed control.  A similar trend was observed in 
primary HBEC lysates (Fig. 2.2D), and apical washes (Fig. 2.2E) at both 1 and 24 h post 
exposure compared to air exposed controls. Overall, the cholesterol concentration did not 
significantly change due to O3 exposure or sample collection time in either 16HBE (4870±597 
ng/sample Air to 5168±138 ng/sample O3) or primary HBE (50121±1554 ng/sample Air to 
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5506±772 ng/sample O3) cells. 
To test the formation of O3-derived oxysterols in humans in vivo, we determined the 
levels of oxysterols identified in BALF obtained from healthy volunteers exposed to filtered air 
or 0.3ppm O3 for 2 h. The BALF was collected by bronchoscopy at 1 and 24 h post-exposure and 
various oxysterol species were quantified by HPLC-MS. Exposure to O3 significantly elevated 
the concentrations of β-EpCh (Fig. 2.3B) and Seco A (Fig. 2.3C) compared to individuals 
exposed to filtered air controls at 1 h post-exposure with p values of less than 0.001 and 0.05 
respectively. A moderately convincing increase (p<0.1) was observed for α-EpCh (Fig. 2.3A) 
and no difference in Seco B (Fig. 2.3D). Unlike the results observed in the in vitro samples, we 
observed that oxysterol concentrations returned to baseline levels 24 h post-exposure.  Again, 
there was no significant change in overall BALF cholesterol concentration in subjects exposed to 
air (6639±1556 ng/mL) compared to O3 (6698±2245 ng/mL).  
The Effects of O3 on Cholesterol Efflux and Cytokine Gene Expression – As expected and 
previously described by us (30, 31), exposure to O3 caused an inflammatory response as marked 
by increased gene expression (Fig. 2.4A/B) and protein concentration (Fig 2.4C/D) of pro-
inflammatory cytokines IL6 and IL8. Treatment with synthetic LXR agonist T0901317 (T09) 
alone did not affect the levels of IL6 or IL8 expression (Fig. 2.4A/B). Interestingly, exposure to 
O3 in the presence of T09 significantly decreased the expression of cholesterol efflux pump 
protein ABCG1 (Fig. 2.4E) and ABCA1 (Fig. 2.4F), suggesting O3-induced inhibition of the LXR 
pathway. Additionally, ABCA1 protein levels were significantly reduced in cells exposed to O3 
compared to air as shown in relative densitometry from 3 separate experiments (Fig. 2.4G) and 
representative immunoblot (Fig. 2.4H). 




compared to WT mice.  Each were exposed to filtered air or 2ppm O3 for 3 h. BALF was 
collected from both conditions and evaluated for concentrations of IL-6. The LXR-α-/- mice 
showed significantly higher concentrations of IL-6 compared to the WT (Fig. 2.5A). At necropsy 
the lungs were removed and homogenized for RNA isolation and qPCR analysis. In a similar 
result, IL-6 mRNA levels were significantly higher in the LXR-α-/- mice exposed to O3 compared 
to the WT control mice exposed to O3 (Fig. 2.5B). As seen in the human BALF samples (Fig. 
2.3C/D), exposure to O3 increases the amount of Seco A (Fig. 2.5C) and Seco B (Fig. 2.5D) in 
the mouse BALF samples with significantly higher amounts of Seco A present in the LXR-α-/- 
compared to the WT mice. Interestingly, unlike the human samples, total cholesterol levels 
decreases in O3-exposed animals (Fig. 2.5E).  
Exposure to a-Seco A Reveals LXR-α Protein Adducts – Based on recent studies 
demonstrating oxysterol-induced lipid-protein adducts, we hypothesized that O3 derived 
oxysterols can adduct to the LXR-α and LXR-β proteins, which contain reactive lysine residues 
(14, 29). Seco A, a primary ozonide and one of the most reactive O3-derived oxysterols, reacts 
with proteins and causes covalent modifications leading to lipid-protein adduct formation (32). 
16HBE cells were treated with alkynyl-tagged Seco A (a-Seco A) and the adducted proteins 
were identified by first adding biotin to the alkynyl tag utilizing click cycloaddition (Fig. 2.6A) 
followed by immunoaffinity purification with streptavidin beads and photo-release (Fig. 2.6B), 
which frees cellular proteins adducted by a-Seco A. This mixture of proteins was subsequently 
subjected to western blot analyses using antibodies against HSP90, LXR-α, LXR-β, PPAR-γ, and 
β-actin (Fig. 2.6C). HSP90 was used as a positive control based on previous studies (33). Our 
data show that treatment of bronchial epithelial cells with a-Seco A results in the formation of 
Seco A-LXR adducts.  
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Alkynyl Cholesterol Supplemented Cells Exposed to O3 Reveals the Formation of LXR-
adducts – 16HBE cells were supplemented with 20 -tagged cholesterol (a-Chol) for 6 
days. Media containing a-Chol changed daily with washes on the apical side 24h prior to 
exposure (Fig. 2.7B). The 16HBE cells were exposed to filtered air or 0.4ppm O3 for 4 h and 
harvested 1 h post-exposure. Our data show that a-Chol, a surrogate of endogenous cholesterol, 
is incorporated into the cells and, in response to O3, generates a host of alkynyl-oxysterols 
identical to the oxysterol species generated via oxidation of endogenous cholesterol (Fig. 2.7A). 
Based on streptavidin analysis, cells exposed to O3 exhibit a higher overall level of protein 
adduction with oxidized cholesterol species than cells exposed to air (Fig. 2.7C). Similar to cells 
treated with a-Seco A, HSP90 and LXR-α were found to be targets of alkynyl-tagged oxysterols 
generated endogenously in cells exposed to O3 (Fig. 2.7D). The broad band of LXR-antibody 
reactive proteins shown in Figure 2.7D (Elute+O3) suggests that a set of O3-derived adducts are 
formed under conditions of endogenous oxysterol genesis.  This is in contrast to the homogenous 
protein adduct observed after exposure to a single exogenous electrophile, as shown in Figure 
2.6C for the experiment with a-Seco A. Figure 2.7E shows the densitometric analysis of O3-
derived adducts of LXR-α from 3 separate experiments.  
Oxysterol Exposure Alters ABCA1, FASN, and SREBP1 Gene Transcription – 
Considering the effects of oxysterols on adduct formation with LXR, we evaluated if exposure to 
oxysterols can alter expression levels of genes controlling cholesterol biosynthesis, fatty acid 
synthesis and cholesterol efflux in 16HBE cells. To determine whether oxysterol adduct 
formation with LXR inhibits subsequent activation of LXR, we sequentially treated 16HBE cells 
with DMSO, Seco A, or T09 for 2 h, removed the first treatment and followed with a second 
challenge for 2 h (Fig. 2.8A). Treatment with Seco A followed by T09 significantly suppressed 
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ABCA1 (Fig. 2.8B), FASN (Fig. 2.8C), and SREBP1 (Fig. 2.8D) gene expression compared to 
cells exposed to DMSO followed by T09 and T09 followed by T09, suggesting that initial 
treatment with Seco A reduces the ability of T09 to enhance cholesterol synthesis and efflux 
gene expression. Challenge with individual oxysterol species yielded no significant change in 
LXRE activity when compared to the DMSO vehicle control (Fig. 2.8E). However, LXRE 
activity was significantly reduced in cells sequentially treated with Seco A followed by T09 
compared to cells sequentially treated with DMSO followed by T09 or T09 followed by T09 
(Fig. 2.8F), again suggesting that initial treatment with Seco A reduces the ability of T09 to 
activate LXR.  
Exposure to Individual Oxysterols Activates the Inflammatory Gene Transcription 
Pathway - In order to determine whether O3-derived oxysterols modify expression of 
inflammatory genes alone and in relation to known agonists, 16HBE cells were sequentially 
treated with DMSO, Seco A or T09 for 2 h followed by a second challenge for 2 h as described 
above (Fig. 2.8A). Exposure to Seco A followed by T09 increased the expression of IL6 (Fig. 
2.9A) and IL8 (Fig. 2.9B) compared to the DMSO treated control. Additionally, individual O3-
derived oxysterol species significantly increased the NF-κB activity compared to the DMSO 
control (Fig. 2.9C), suggesting that O3-derived oxysterols enhance pro-inflammatory pathways.  
 
2.5 Discussion 
Despite a large body of research on O3-induced toxicity and adverse health effects, the 
biochemical and cellular signaling cascades induced by O3 exposure in the human airways are 
not fully understood. O3 is a known oxidant of the macromolecules in the airway lining fluid and 
the formation of many oxidized lipid products has been previously described along with their 
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biochemical effects. For example, instillation of 5beta,6beta-epoxycholesterol (β-EpCh) and 1-
palmitoyl-2-(9'-oxo-nonanoyl)-glycerophosphocholine (PON-GPC), which are both formed 
during O3 exposure, causes neutrophilic influx, which in turn was regulated by class A scavenger 
receptors, known to bind oxidized lipids (3). Ozonization of phospholipids generates products 
with strong pro-inflammatory effects (8, 9). Additionally, O3 is known to react with lung 
surfactant proteins, modifying and inhibiting their normal biological functions (34-36). O3 
induced oxidized cholesterol products, however, have only partially been described in their 
effects on the biological properties of the human airway.  Through this study, our results address 
the knowledge gap between O3 induced cholesterol oxidation in the airway and downstream 
cellular signaling events. Our data demonstrate that O3-derived oxysterols can form lipid-protein 
adducts with cellular signaling molecules, revealing a new paradigm that lipid-protein adduct 
formation provides a central mechanism for O3-derived oxidized lipids to modify cellular 
responses.  
Lipid protein adduction as a means to alter normal signaling has been shown to occur 
during exposure to other oxidative stressors, including the free radical induced formation of 4-
hydroxynoneal (HNE) (37, 38). While formation of oxysterols following exposure to O3 has 
been shown before (28, 35), whether and how these O3-derived oxysterols can form oxysterol-
protein adducts in the context of O3 exposure in the human airway has not been examined. 
Assays based on “click” cycloaddition methods make it possible to visualize protein-lipid 
adducts via immunostaining and determine protein adductions with specific signaling molecules, 
thus providing novel insight into the mechanisms behind O3-induced adverse health effects (39). 
Using this approach, our results demonstrate the formation of oxysterol-protein adducts in 
airway epithelial cells as a result of exposure to O3. The synthetic O3-derived oxysterol Seco A 
53 
 
has previously been described as a highly reactive ozonolysis product capable of adducting with 
the lysine amino acid residues on various proteins (29). Through our study, we determined that 
O3-derived oxysterols, including Seco A, can effectively form adducts with proteins LXR-α, 
LXR-β and PPAR-γ, which all regulate lipid metabolism (40, 41). Additionally, supplementation 
with alkynyl-tagged cholesterol reveals that in the human airway, exposure to O3 generates 
reactive oxysterols capable of forming adducts with the LXR-α and HSP90 proteins. The 
comparatively diffuse band observed in Figure 2.7D and quantitatively analyzed in Figure 2.7E 
is most likely indicative of a heterogeneous mixture of O3-derived oxysterols being formed that 
can adduct LXR and of a variety of post-translational modification to LXR-α in addition to a-
Seco A adduction resulting in a mixture of proteins recognizable by the anti- LXR-α antibody. 
Hence, data presented here reveals a novel biochemical mechanism involving the conversion of 
cellular cholesterol by O3 into reactive oxysterol species, a process that results in the adduction 
of key proteins and modification of cellular signaling.  
The formation of adducts between O3-derived oxysterols and LXR provides a model 
signaling mechanism, which results in modifications of airway inflammatory and cholesterol 
homeostasis signaling. Endogenous oxysterols are known to be formed during normal cholesterol 
regulation and metabolism. These compounds play a role in normal LXR activation, promoting 
cholesterol homeostasis. Mouse model systems with LXR and cholesterol efflux deficiencies 
have higher cholesterol accumulation, potentiated atherosclerosis, and are more susceptible to 
systemic infection (42). These effects occur partially via the endogenous oxysterol-induced 
activation of LXR and transcriptional activation of genes such as ABCA1, which mediate 
cholesterol shuttling and ultimately packaging into HDL (43, 44). In contrast, our data show that 
in human bronchial epithelial cells, O3 exposure decreases the expression of ABCA1, suggesting 
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that O3 or its oxidation products have an inhibitory effect on the transcriptional activation of 
ABCA1. Decreased ABCA1 expression and subsequent decreased cholesterol efflux may result in 
accumulation of intracellular cholesterol leading to dyslipidemia and propagation of respiratory, 
metabolic, and cardiovascular health problems (13, 45). Whether the observations related to O3-
induced suppression of ABCA1 expression affects systemic cholesterol metabolism and 
potentially contributes to the enhanced atherosclerosis and cardiovascular events associated with 
O3 exposure remains to be established. In addition to cholesterol homeostasis, previous studies 
have indicated that normal LXR activation is necessary for immune health. LXR activation by 
synthetic agonists leads to decreased neutrophil recruitment and increased bacterial burden, 
indicating that LXR activation balance contributes to host immune defense (46). Recent studies 
also suggest that LXR agonists show therapeutic promise in treating lung disorders such as 
dyslipidemia and asthma (43, 47, 48). Further, our data show that O3 exposure of LXRα
-/- mice 
results in enhanced pro-inflammatory response, indicating the importance of normal LXRα 
activity to regulate O3 induced inflammation (Fig. 2.5A/B). The enhanced concentration of O3 
derived oxysterols in the BAL sampled from the LXRα-/- mice further link airway cholesterol 
ozonolysis and LXRα activity. It is interesting that overall cholesterol levels were reduced in 
these mice exposed to O3, a change we did not observe in our human subjects BALF.  Taken 
together, LXR dysfunction caused by O3-derived oxysterols may contribute to enhanced 
respiratory inflammation and adverse cardiovascular health effects in humans exposed to O3.  
Based on our observation of adduct formation between O3-derived oxysterols and LXR, 
we hypothesize that electrophilic O3-induced oxysterols and their derived lipid protein adducts 
inhibit cholesterol signaling pathways that are normally activated by endogenous oxysterols. Our 
data in Figure 2.8E show that O3-derived oxysterols alone are not themselves potent activators of 
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LXR , but that treatment with Seco A prior to activation of LXR by the agonist T09 reduces T09-
induced LXRE activation as well as expression of ABCA1, FASN, and SREBP1. These data 
suggest that Seco A-induced adduct formation with LXR may prevent its activation with known 
agonists, such as T09, or endogenous oxysterols, such as 27-hydroxycholesterol (49). Our 
previous studies have demonstrated that Seco A readily adducts to nucleophilic lysine amino 
acid residues in human serum albumin and other protein and we hypothesize a similar binding 
site in LXR (29).  LXR contains eight lysines in a ligand binding domain (amino acids 215-434) 
that are capable of binding both oxysterol and T09 ligands (14).  Based on our results, we 
propose that O3-derived oxysterols block T09 mediated LXR activation either by non-
competitive binding to the same site or by modifying LXR structure to inhibit normal ligand 
binding. Additional studies are necessary to clarify the nuclelophilic peptide site of O3-derived 
oxysterol LXR adduct formation.  
In contrast to expression of ABCA1, expression of IL6 and IL8 as well as activation of 
NF-κB was enhanced by exposure to Seco A and other O3-derived oxysterols. O3 is known to 
activate NF-κB leading to increased transcription of inflammatory cytokines such as IL6 and IL8 
(31, 50, 51). Similarly, other lipid ozonization products have been shown to activate IL6 and IL8 
in human airway epithelial cells (9). Our study shows that O3 derived oxysterols enhance 
activation of NF-κB and potentiate the transcription of IL6 and IL8. LXR signaling has been 
shown previously to have an inhibitory effect on NF-κB and inflammatory signaling in epithelial 
cells (52, 53), making it a reasonable target for O3 derived oxysterol-induced modification of 
inflammatory signaling. All the O3-derived oxysterol species we tested increased NF-κB activity, 
revealing that in their presence, airway epithelial cells may experience increased inflammatory 
signaling leading to adverse health effects. In the experiments using sequential stimulation with 
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Seco A and T09, stimulation with Seco A alone, regardless of the secondary stimulus, increases 
IL6 and IL8 expression, indicating that O3-derived oxysterols potentiate the transcription of pro-
inflammatory cytokines. In addition to directly activating the NF-κB pathway, we hypothesize 
that this effect may be linked to inactivation of LXR. Activation of LXR induces a number of 
anti-inflammatory responses, marked by inhibition of NF-κB activity and decreased production 
of pro-inflammatory mediators (54). Previous rodent studies show the use of LXR agonists to 
inhibit NF-κB activation in order to reduce lung injury and inflammation after hemorrhage and 
resuscitation (55).  In this role, LXR is not recruited to LXR response elements in genes related 
to lipid metabolism, but participates in a transrepression mechanism of NF-κB, resulting in 
inhibition of inflammatory genes such as IL-6 (42, 56, 57). LXR activity is controlled by a post-
translational SUMOylation modification and interaction with nuclear receptor co-repressors, 
reducing NF-κB activity. (58-60). The proposed SUMOylation occurs at the lysine residues of 
LXR ensuring RXR dimerization and nuclear translocation (60). Thus, lipid-adduct formation at 
or near these lysine residues may prevent SUMOylation of LXR, interaction with co-repressors, 
and consequently activation of NF-κB. This proposed signaling mechanism provides a link 
between our observed O3-derived oxysterol induced changes to LXR signaling and a model for 
O3 induced NF-κB activation.  
In order to enhance our understanding of O3 induced cardiovascular events and 
atherosclerosis, whether the biochemical mechanisms involving O3-derived oxysterols, adduct 
formation with LXR, and reduced ABCA1 expression are reflected in systemic changes needs to 
be examined. Interestingly, epidemiological studies repeatedly demonstrate the beneficial effects 
of cholesterol modifying drugs, such as statins, on air pollutant-induced adverse health effects 
(61-65). Yet, the mechanisms mediating these effects are unknown and have often been ascribed 
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to the anti-inflammatory effects of statins. The findings presented in this study provide an 
additional explanation for the beneficial effects of statins on the response to inhaled O3. 
Therapeutic treatment with lipid-targeting agents such as statins may reduce cholesterol 
availability in the airways, thus reducing oxysterol formation, and leading to changes in O3 
induced inflammation.  
Collectively, our results suggest that reactive oxysterols formed in the airways following 
O3 exposure interact with the LXR signaling pathway, alter expression of genes that regulate 
cholesterol efflux, fatty acid synthesis, and cholesterol regulation, and enhance pro-inflammatory 
signaling pathways known to be associated with O3 exposure. Our findings indicate that 
cholesterol availability is paramount to the formation of O3-derived oxysterols in the airway and 
may provide a novel therapeutic target to reduce the adverse effects associated with ambient O3 
exposure. In addition to LXR examined here, other proteins are also likely targets for adduction 
by O3-derived oxysterols and warrant future study into their implications in O3 induced airway 
inflammation.  Together, our data describe a novel mechanistic concept linking O3 reactions with 
cholesterol moieties in the human airway and its impact on health outcomes. Our data also 
highlight the use of samples derived from human in vivo O3 exposure as well as primary HBECs 
and 16HBE cells to provide clinical and biological relevance for O3 derived oxysterol and their 


















Figure 2.2: Oxysterol concentrations measured in cells and apical washes exposed to 
filtered air or O3 and their HPLC-MS profiles. All cells were grown in 24mm Transwell 
membrane plate until confluency followed by removal of the apical medium and exposure to 
filtered air or 0.4 ppm O3 for 4 h. Cell lysates and apical washes were collected at 1 and 24 h 
post-exposure. (A) Representative reverse-phase HPLC-MRM chromatograms of epithelial cells 
exposed to air or 0.4 ppm ozone.  MS for each panel is selected reaction monitoring (SRM) of 
the m/z indicated in the air exposure. (B) 16HBE cell lysate, (C) 16HBE apical wash, (D) 
primary HBEC cell lysate, (E) primary HBEC apical wash. Data are presented as mean ± SEM. 
Statistical analysis was performed with a one-way ANOVA and Fisher’s LSD post hoc test 






Figure 2.3: Oxysterol concentrations measured in airway BALF Healthy individuals were 
exposed to either filtered air (control) or 0.3 ppm O3 for 2 h. Cell free BALF was collected by 
bronchoscopy at 1 and 24 h post-exposure. Oxysterols were quantified by HPLC-MS 
spectrometry. (A) α-EpoxyCholesterol (α-EpCh), (B) β-EpoxyCholesterol (β-EpCh), (C) 
Secosterol A (Seco A), (D) Secosterol B (Seco B). Data are presented as mean ± SEM. Statistical 
analysis was performed with paired student’s t-test (two tailed distribution, pairing based on 





















Figure 2.4: Cholesterol efflux pump protein and pro-inflammatory cytokines gene 
expression levels in 16HBE cells. Cells were exposed to filtered air or 0.4 ppm ozone for 4 h 
-exposure 
and analyzed. Inflammatory gene expression levels (A) IL-6, (B) IL-8, and protein levels (C) IL-
6, (D) IL-8; as well as gene expression levels for (E) ABCG1 and (F) ABCA1 were measured. 
Additionally, ABCA1 protein levels were evaluated by (G) immunoblot and (H) relative 
densitometry from 3 separate experiments. Data are presented as mean ± SEM. Statistical 
analysis was performed with a one-way ANOVA and Fisher’s LSD post hoc test comparing 
observed means against the respective treatment/air-exposed control, *p<0.05, or against the 
DMSO/air exposed vehicle control, #p<0.05, n=3. 
62 
 
Figure 2.5: IL-6 expression and production in the lung of O3 exposed LXRα deficient mice. 
Wild Type (WT) and LXR-α-/- female mice were exposed to filtered air (Air) or 2ppm O3 for 3 
h. Mice were necropsied 6h after start of exposure. (A) Bronchoalveolar lavage was collected 
and evaluated for IL-6 cytokine concentrations by ELISA. (B) After necropsy lung tissues were 
collected for RNA isolation and evaluated for gene expression of IL-6 and 18S. Brochoalveolar 
lavage was also evaluated for (C) total Seco A, (D) total Seco B, and (E) total cholesterol. Data 
was presented as mean ± SEM. Statistical analysis was performed with Mann-Whitney test 





Figure 2.6 Simplified steps of protein catch and photo-release using a-Seco A probe in 16 
HBE cells. Supplementation with a-Seco A (20 µM) in 16HBE cells for 4 h at 37 °C followed by 
cell lysis and click reaction to introduce biotin for immuno affinity purification. A single aliquot 
was taken to probe the extent of alkyne labeling via biotin-streptavidin interaction.  The rest of 
clicked cells were immobilized onto Streptavidin beads to catch only adducted proteins and 
remove un-adducted proteins. Subsequent photo-release permitted to collect adducted proteins. 
(A) IRDye® 800CW Streptavidin visualization exhibits the extent of protein labeling with a-
Seco A. (B) SDS Page gel of photo-released proteins. An equal amount of total protein was 
loaded. The a-Seco A treated cells (right 2 lanes) exhibited significant protein adduction 
compared to the input lanes (left 2 lanes). (C) Selective antibody analyses indicate adduction on 
HSP90, LXR-α, LXR-β, and PPAR-γ proteins. Anti-actin of the input lane provides another 














Figure 2.7: Protein adduct formation is observable in 20 µM a-Chol supplemented 16HBE 
cells exposed to O3. Following a-Chol supplementation (20 µM), apical medium was removed 
and the cells were exposed to clean air or 0.4 ppm O3 for 4 h. Cells were harvested after 1 h post-
incubation (A) Lipids were extracted as described in experiment. LC-SRM profile demonstrates 
that a-cholesterol was incorporated into the cells and generated ozone derived oxysterols as those 
of endogenous cholesterol. (B) Schematic depicting a-Chol supplementation prior to O3 
exposure. (C) Cells harvested in lysis buffer containing inhibitors were clicked with azido-biotin. 
IRDye® 800CW streptavidin probe displays significantly extent of protein adduction upon O3-
exposed cells where as background level of adduction with air-exposed cells were observed.  
Anti-Actin is served as a loading control. (D) HSP90 and LXR-α westerns of click and photo-
released proteins. 16HBE cell lysates were loaded as a positive control. (E) Relative 






Figure 2.8: Seco A altered cholesterol efflux pump gene expression when treated with Seco 
A and the T09 LXR agonist in sequence. (A) Experimental design depicting how 16HBE cells 
were challenged for 2 h to 20 µM of Seco A, 10 μM T09, or DMSO control for first challenge, 
media removed and followed by 2 h of second challenge. Samples were evaluated for (B) 
ABCA1, (C) FASN, and (D) SREBP1 gene expression. LXRE activity was measured in relative 
light units compared to the respective vehicle control in the (E) individual oxysterol challenges at 
20μM for 4h and (F) sequential treatment in 16HBE cells. Data are presented as mean ± SEM of 
fold change compared to the DMSO control. Statistical analysis was performed with a one way 
ANOVA and Fisher’s LSD post hoc comparison test, *significantly different from the DMSO 









Figure 2.9: Oxysterol altered inflammatory signaling. A) IL6 and B) IL8 gene expression in 
sequential challenge of 2 h with first challenge followed by another 2 h of second challenge on 
16HBE cells exposed to 20 μM of Seco A, 10 µM T09, or DMSO control on collagen coated 
plates. C) Relative light units of NF-κB promoter reporter activity in 16HBE cells exposed to 20 
μM of various oxysterols, 20 ng/mL TNF-α, or DMSO negative control for 4 h on collagen 
coated plastic. Data are presented as mean ± SEM of fold change compared to the DMSO 
control. Statistical analysis was performed with a one way ANOVA and Fisher’s LSD post hoc 
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CHAPTER 3: OZONE-DERIVED OXYSTEROL-PROTEIN ADDUCTS MODIFY 
NLRP2 INAIRWAY EPITHELIAL CELLS  
3.1 Overview 
Despite the abundance of studies examining the adverse health effects of ozone (O3) 
exposure and its association with increased airway inflammation, the mechanisms mediating 
these responses have yet to be fully described. Previous studies, including our own, have shown 
that exposure to O3 results in the formation of electrophilic lipid peroxidation products, notably 
through the oxidation of cholesterol in epithelial cells. These electrophilic oxysterols are capable 
of forming covalent linkages with nucleophilic functional groups on proteins, particularly lysine 
residues, thus potentially altering cellular signaling pathways. Much remains to be learned about 
the identity of the reactive lipid species and the range of potential proteins modified by the 
oxysterols in the lung, as well as the biological consequences. In this study, airway epithelial 
cells were exposed to the O3-derived oxysterol alkynyl Secosterol-A and 2D LC-MS/MS shotgun 
proteomics was used to generate a database of oxysterol-protein adducts. NLR Family Pyrin 
Domain Containing Protein 2 (NLRP2) was among oxysterol-adducted proteins and bio-
orthogonal cycloaddition was used to confirm oxysterol-NLRP2 adduct formation to lysine 
K1019 in the LRR protein region, a region known to influence inflammasome complex 
formation. Utilizing qPCR and western blotting, abundance of NLRP2 in airway epithelial cells 
was compared with other prominently studied NLR proteins. In addition, O3-induced expression 
of NLRP2 and association with other inflammasome proteins was tested. To determine the role 
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of NLRP2 in O3-induced inflammation, we knocked down NLRP2 expression in human airway 
epithelial cells followed by analysis of inflammasome complex formation and inflammatory 
mediator production. Our data show that NLRP2 is the most abundantly expressed member of 
the NLRP family in human airway epithelial cells. Oxysterol-NLRP2 adduction occurred in the 
leucine-rich-repeat region, which regulates the activity in other NLRP-inflammasome 
complexes. We also show that exposure of epithelial cells to O3 further increases NLRP2 
expression, activates caspase-1 cleavage, and enhances markers of inflammasome complex 
assembly, suggesting that O3 leads to the formation and activation of NLRP2 inflammasome 
complexes. Knockdown of NLRP2 alone reduces O3-induced inflammation and we can 
recapitulate this reduction in inflammasome cytokine signaling by impeding downstream NLRP2 
IL-1β and IL-18 signaling with targeted caspase-1 and IL-1 receptor inhibition. Together our 
findings further support the notion that oxysterol-NLRP2 adduct formation could be mediating 
O3-induced inflammation through a decrease in mature IL-1β and IL-18 production. We show for 
the first time that NLRP2 is highly abundant in airway epithelial cells and a key component of 
O3-induced inflammation. Our data further demonstrate that formation of oxysterol-protein 
adducts with NLRP2 is a novel mechanism mediating O3-induced pro-inflammatory responses.  
3.2 Introduction 
Numerous in vitro and in vivo studies have demonstrated that exposure to O3 causes rapid 
activation of the NF-κB signaling pathway, generating pro inflammatory mediators and leading 
to the infiltration of inflammatory cells into the airways (1-4). Yet, mechanisms linking the 
known chemical reactivity of O3 and its reaction products with biological effects continue to 
present a knowledge gap.  
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Studies have shown that O3 reacts directly with sulfhydryl groups in proteins and small 
molecules, such as ascorbate, glutathione, and urate, and has the ability to form ozonides with 
unsaturated lipids such as phosphatidylcholines and cholesterol which are abundantly present in 
the airway surface liquid (5). O3-derived products of lipid oxidation, including electrophiles such 
as lipid ozonization products (LOPs) and oxysterols, are capable of independently forming 
protein adducts and altering normal cellular function (6). A series of studies in the field of O3-
induced lipid peroxidation suggested that LOPs alone could recapitulate O3-induced activation of 
NF-κB and pro-inflammatory mediator production (7,8). Similarly, 4-hydroxynonenal (4-HNE), 
formed during phospholipid peroxidation, causes covalent modification of proteins and also 
mimics O3-induced biological effects (9,10). Moreover, our research team’s recent studies have 
focused on the formation of O3-derived oxysterols (11-13). While their presence has been 
measured in the lung and in atherosclerotic plaques, few studies have been conducted examining 
their impact on inflammatory response in the human airway following O3 exposure.  
In the human lung, enzymatically generated oxysterols formed during normal cholesterol 
metabolism perform anti-inflammatory and immune-modulatory functions (14).  In contrast, 
oxysterols formed via ozonolysis of cholesterol are highly electrophilic and lead to the formation 
of covalent linkages with proteins, modifying normal function (13). Rodent studies and our own 
human in vivo and in vitro exposure studies demonstrate that O3 exposure increases the 
abundance of several electrophilic oxysterol species in epithelial cells and airway surface liquid 
and that these oxysterols can increase NF-κB activity in airway epithelial cells (6,15). In 
addition, our previous studies indicate that while endogenously formed oxysterols activate the 
liver-X-receptor (LXR) and are anti-inflammatory (16), O3-derived oxysterols inhibit the LXR 
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pathway and are pro-inflammatory, suggesting opposing functions of endogenously formed and 
ozonolysis-derived oxysterols (12).  
Biochemical analysis indicates that electrophilic O3-derived oxysterols react with 
nucleophilic centers of proteins (largely lysine residues), forming oxysterol-protein adducts, 
which could affect the function of these proteins (13), thus providing a new paradigm linking O3-
induced chemical modification of lipids with changes in protein function. As depicted in Figure 
3.1 and discussed previously in Chapter 2, our previous data demonstrated O3-induced 
generation of oxysterols, such as Secosterol A (Seco A), in humans in vivo and epithelial cells in 
vitro and are capable of forming protein adducts (12). Based on this study we designed 
experiments to conduct an unbiased assessment of the overall “adductome”. Specifically, we 
developed experimental protocols in which airway epithelial cells were treated with alkynyl-
modified O3-derived oxysterols, followed by reaction of cell lysates with an azido biotin reagent 
under “click” cycloaddition conditions. This sequence of reactions results in the biotinylation of 
any protein that forms a covalent bond with a-Seco A (17). The immunoprecipitated and photo-
eluted fraction was analyzed for the overall “adductome” in epithelial cells using 2D LC-MS/MS 
shotgun proteomics, thus identifying potentially novel targets for O3-derived oxysterols. The 
findings detailed in this study identify NLRP2 as a highly abundant oxysterol-adducted protein, 
which regulates O3-induced inflammatory responses in epithelial cells, thus uncovering a novel 
signaling mechanism regulating the inflammatory effects caused by O3 exposure in the human 
airway. Our study demonstrates that assessment of the O3-derived oxysterol “adductome” in 
human airway epithelial cells has the potential to uncover novel cellular targets and mechanisms 




3.3 Materials and Methods 
Reagents - Alkynyl-probes were synthesized following the procedures published 
previously (2,13,18). DTT and iodoacetamide were purchased from Sigma Aldrich (St Louise, 
MO).  Streptavidin beads were purchased from GE Healthcare (Piscataway, NJ). The following 
reagents were purchased from their respective companies: 10% NuPage Novex Bis-Tris® precast 
mini gel (Invitrogen, Grand Island, NY), PVDF membrane and Simply Blue (Bio Rad, Hercules, 
CA), IRDye®  800CW Streptavidin (925-32230, Li-Cor, Lincoln, NE), Blocking buffer 
(Rockland, Gillbertsville, PA or Odyssey Blocking buffer, Li-Cor, NE). Sequencing grade 
Trypsin (Promega V5111, Madison, WI). NLRP2 antibody was obtained from R&D Systems 
(Minneapolis, MN) Antibodies of NLRP3, NLRP1, and HIS3 were obtained from Cell Signal 
Technologies (Danvers, MA), ASC and Actin were from Santa Cruz (Dallas, Texas). Cell 
Culture - 16HBE14o (16HBE) cells, a SV-40 transformed human bronchial epithelial cell line 
were a gift from Dr. D. C. Gruenert (University of California San Francisco, San Francisco, CA). 
16HBE cells were plated on fibronectin-coated (LHC Basal Medium [Life Technologies, 
Carlsbad, CA], 0.01% BSA [Sigma, St. Louis, MO], 1% Vitricol [Advanced Bio Matrix, San 
Diego, CA], and 1% human fibronectin  [BD Biosciences, San Jose, CA]) 0.4µm Transwell® 
plates(Costar, Corning, NY), and grown submerged in minimal essential media (Gibco) with 
10% FBS, 1% penicillin-streptomycin, and 1% L-glutamine (Life Technologies) until confluent 
for 6 days, and 1 day at air-liquid interface (ALI) before use. Primary human bronchial epithelial 
cells (HBEC) were obtained from healthy donors in collaboration with the Environmental 
Protection Agency (EPA) using a protocol approved by the University of North Carolina at 
Chapel Hill Institutional Review Board (Chapel Hill, NC), as described previously (19). The 
HBECs were cultured in Pneumacult medium for 21 days to differentiate according to previously 
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described methods (20,21). 
In Vitro O3 Exposure - Cultures at ALI were exposed to filtered air or 0.4ppm O3 for 4 
hours in exposure chambers operated by the U.S. EPA, as previously described (22). The dose 
was selected for maximal innate immune response to O3 with minimal cytotoxicity and has been 
used previously by our group (21). At 1 or 24 h after exposure, apical sides of all cultures were 
washed with 100 µL Hanks’ balanced salt solution (HBSS) (Life Technologies) and saved for 
LC-MS analysis. The remaining cells were collected in 200 µL PBS, centrifuged at 500 g for 5 
min, and were stored at -80 °C until LC-MS analysis. 
Real-time qPCR - Total RNA was isolated from 16HBEs and HBECs with the use of the 
Pure Link RNA Mini Kit (Life Technologies, Carlsbad, CA). First strand cDNA preparation and 
real-time quantitative PCR (qPCR) were performed as previously described (23,24). Primers and 
probes for NLRP1, NLRP2, NLRP3, NLRP7, NLRP12, and β-actin were commercially available 
(Applied Biosystems, Foster City, CA). Human IL8: 5’-FAM-
CCTTGGCAAAACTGCACCTTCAC-TAMRA-3’ (probe), 5’-
TTGGCAGCCTTCCTGATTTC-3’ (sense), and 5’-
TATGCACTGACATCTAAGTTCTTTAGCA-3’ (antisense) and IL6: 5’-FAM-
CCAGCATCAGTCCCAAGAAGGCAACT-TAMRA-3’ (probe), 5’-
TATGAAGTTCCTCTCTGCAAGAGA-3’ (sense), and 5’-TAGGGAAGGCCGTGGTT-3’ 
(antisense) were prepared in-house.  Differences in expression were determined with the ΔΔCt 
method and β-actin for normalization. Threshold cycle (Ct) value for the housekeeping gene (β-
actin) was subtracted from the Ct value for the gene of interest to determine the ΔCt value. For 
each pairwise set of samples to be compared, the difference in ΔCt values between the two 
samples were calculated for the genes of interest to determine the ΔCt value. The fold change in 
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gene expression was calculated as 2-ΔΔCt. 
Sterol profiling using PTAD derivatization and LC-SRM Analysis. Cells were scraped 
into 400μL cold PBS. 200 of the 400 µL were taken and internal standards added (13 ng for d7-
7-DHC, 97 ng for 13C3-Desmosterol and 99 ng for 13C3-Lanosterol, and 342 ng for d7-
Cholesterol/sample), 10 µL butylated hydroxytoluene (BHT)/triphenylphosphine (TPP) solution 
(2.5 mg TPP and 1 mg BHT in 1 mL MeOH), 400 µL 1% NaCl, and 500 µL Folch solution 
(2:1=CHCl3:MeOH).  Cells and standards were vortexed vigorously and centrifuged at 3099 x g 
for 5 min. CHCl3 layer was removed and added to PTAD-predeposited tube (200 μg/tube). The 
sample tubes were vortexed and analyzed by LC-MS using the following conditions: 10 μL was 
injected onto the column (Acquity UPLC BEH C18, 1.7 μm, 2.1 x 50 mm) with 100% MeOH 
(0.1% acetic acid) mobile phase for 1 min runtime at a flow rate of 300 μµL/min. The monitored 
transitions included: 7-DHC m/z 560→365, d7-7-DHC m/z 567→372, desmosterol m/z 
592→365, 13C3-desmosterol m/z 595→368, lanosterol m/z 634→602, 13C3-lanosterol m/z 
637→605 with retention times of 0.8, 0.5, and 0.6 min, respectively. 
Oxysterol Extraction from 16HBE or HBEC cells. - To the cell pellets, 10 µL alkynyl-
Cholesterol (a-Chol) (25ng/µL), 500 μL NaCl (0.9%), 10 μL of TPP and BHT (25 mg TPP and 
10 mg BHT in 10 mL MeOH), 1 mL of Folch solution (2:1=CHCl3:MeOH) were added. The 
mixture was mixed vigorously by vortex for 2 min and separated by centrifugation with 2300 x g 
for 3 min. The collected organic layer (bottom layer) was evaporated to dryness in a SpeedVac™ 
concentrator and resuspended in 100 µL MeOH for LC-MS analysis. 
LC-MS Analysis - The resuspended samples were chromatographed by RP-HPLC using a 
UPLC BEH C18 column (1.7 μm, 2.1 mm × 100 mm) in Waters Acquity UPLC system equipped 
with an autosampler (Waters, Milford, MA) and either ESI or APCI in positive ion mode. For 
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ESI, the oxysterols were separated by 95% solvent B in an isocratic method with a flow rate of 
200 L/min, and the mobile phase solvents consisted of 2 mM NH4OAc (solvent A) in water and 
2 mM NH4OAc in MeOH (solvent B). The injection volume was 10 μL using a partial loop with 
needle overfill mode. MS detections were done using a TSQ Quantum Ultra tandem mass 
spectrometer (ThermoFisher, Waltham, MA), and data was acquired and analyzed using a 
Thermo Xcalibur™ 2.2 software package. The cholesterol and oxysterols form [M+NH4]+ ions 
in positive ion mode. The transitions monitored were m/z 436→383 for Seco A/B, m/z 418→365 
for a-Seco A/B, m/z 404→369 for cholesterol (Chol), m/z 386→351 for a-Chol, m/z 420→385 
for EpCh, m/z 402→367 for a-EpCh. For APCI, 95% MeOH in H2O containing 0.01% acetic 
acid was used as a mobile phase. The cholesterol and oxysterols form [M+H]+ ions in positive 
ion mode. The transitions were m/z 369→369 for Chol, m/z 383→383 for Seco A/B, m/z 
351→351 for a-Chol, m/z 385→385 for EpCh. The transitions of cholesterol and cholesterol 
esters were m/z 365 →365 monitored by HPLC-MS following the method described elsewhere 
(25). The amount of the cholesterol esters was found to be less than 2% of free cholesterol in the 
cells studied. 
Protein Cytokine Analysis: Concentration of IL-6 and IL-8 in the collected basolateral 
media of 16HBE cells exposed to O3 was determined by enzyme-linked immunosorbent assay 
(ELISA) according to the manufacturer instructions (BD Biosciences, San Jose, CA). 
Immunoprecipitation and Western Blotting: Cell lysates from 16HBE cells exposed to 
air/ O3 or O3 derived oxysterols were separated by 10% SDS-PAGE and transferred to 
nitrocellulose. Proteins were detected using specific antibodies: ASC (1:500), NLRP1 (1:1000), 
NLRP2 (1μg/ml), NLRP3 (1:1000), or β-actin (1-2000), which served as a loading control. 
Antigen-antibody complexes were incubated with horseradish peroxidase-conjugated secondary 
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antibody and were detected using chemiluminescence. Immunoprecipitation of NLRP2 bound 
ASC was performed using 1mg of whole cell lysate incubated overnight with NLRP2 antibody at 
4oC followed by addition of an equal volume of Protein A agarose beads (Thermo Scientific 
20333) and incubation at RT for 2 h. The agarose bound protein was washed with 500µL IP 
buffer (25mM Tris, 150mM NaCl; pH 7.2) 3 times and washed once with 500µL ddH2O. The 
protein was eluted by adding 40µL of 5X Loading Buffer with 2-mercaptoethanol (Sigma 
M3148) and heated to 95oC for 5 minutes. The samples was then separated on a 10% SDS-
PAGE gel and transferred to nitrocellulose (BioRad 1620070). Proteins were detected using 
specific antibodies noted above and antigen-antibody complexes were incubated with 
horseradish peroxidase-conjugated secondary and detected using chemiluminescence.  
Cell Culture and Whole Cell Labeling with a-Seco A in 16HBE - 16HBE cells were 
plated 2 x 106 in 10 cm plates using the conditions described above, then allowed to settle and 
grow for 24 h. The cells were then incubated in the presence of a-Seco A (20 μM) and reduced 
FBS levels (2%) in MEM medium for 4 h. Cells were harvested in lysis buffer (50 mM HEPES, 
150 mM NaCl, 0.1% TritonX100, pH=7.0) containing protease inhibitors (Sigma P8340) on ice. 
The lysate was cleared by centrifugation at 10,000 x g for 10 min @ 4 °C to remove cellular 
debris.  The total protein concentration was determined using standard BCA assay (Pierce, 
ThermoFisher) and utilized for click reaction assay. 
Cell Culture and Whole Cell Labeling with a-Cholesterol Followed by Ozone Exposure 
in Human Bronchial Epithelial Cells (16HBE) - 16HBE cells were grown in 24 mm transwells 
submerged in MEM with reduced FBS containing 20 μM a-Chol for 6 days. The apical media 
was removed 24 h before exposure. Next, the plate was exposed to filtered air or O3 (0.4 ppm) 
for 4 h and allowed to continue incubating for an additional 1 h without O3 (1 h post incubation). 
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Cells were harvested in 300 uL lysis buffer/well and analyzed as described above. 
Click Biotinylation of a-Seco A/a-oxysterols Adducted Proteins in 16HBE and 
Streptavidin Affinity Purification - Our previous studies with a model protein (13) and 16HBE 
cell line (12) has shown rapid modification of proteins using an alkynyl tagged alkynyl-
secosterol A (a-Seco A) and “click cycloaddition methods to capture modified proteins. This 
approach makes generating an inventory of the total “secosterol-adductomes” in EC possible by 
the workflow shown in Figure 3.2. In short, a-Seco A treated cells were lysed and “click” reacted 
with a photo-cleavable azido-biotin. Streptavidin visualization from a small portion of cell lysate 
showed a host of cellular proteins adducted by a-SecoA. After streptavidin confirmation of 
adduct formation, the remaining lysate was precipitated in cold MeOH and excess click reagents 
were removed. The precipitated and washed cell pellets were re-suspended in PBS in the 
presence of streptavidin beads to pull down the adducted proteins and after 2 h, the beads were 
washed sequentially with SDS, urea, NaCl, and ammonium bicarbonate to remove the unbound, 
and therefore un-adducted, proteins. The washed beads were exposed to a small portable UV 
lamp (365 nm) for 2 h to release the adducted proteins and the freed protein adducts were dried 
and then re-suspended in LDS buffer followed by a short stacking SDS-PAGE run. The blue 
stain shows that an array of proteins with a broad range of molecular weights had formed adducts 
with a-SecoA. The stained gels were excised followed by in-gel trypsin digestion and the 
digested peptides were extracted from the gel, dried, and reconstituted for MudPIT LC-MS/MS 
analysis. 
Visualization of Biotinylated Proteins Adducted with a-SecoA/a-Oxysterols - The saved 
50uL of click-reaction mixture was mixed with SDS sample loading buffer and resolved using 
10% NuPAGE Novex BisTris® gel (Invitrogen, Carlsbad, CA). The proteins were 
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electrophoretically transferred to a polyvinylidene difluoride (PVDF) membrane (BioRad, 
Hercules CA) and probed with IRDye® 800CW Streptavidin (Li-Cor, Lincoln, NE). The extent 
of adduction was visualized using Odyssey Infrared Imaging System™. 
Immunoblotting Analysis of Photo-released Proteins - The photo-released and dried 
proteins were reconstituted in 70μL PBS, 25μL LDS buffer, and 5μL of 1M DTT and resolved 
by 10% NuPAGE Novex BisTris® gel then transferred to PVDF membrane. The transferred 
proteins were incubated with antibodies of NLRP2 (anti-mouse, R&D), Histone H3 (anti-mouse, 
Cell Signaling), overnight in the cold room at 4 °C. Alexa Fluor 680® labeled secondary anti- 
mouse was used to detect target proteins. Immunoreactive proteins were visualized using 
Odyssey Infrared Imaging System™ (Li-Cor, Lincoln, NE). 
Anakinra/Cas1 Inhibition of inflammatory signaling in 16HBE cells – As described 
above, 16HBE cells were cultured at ALI until formation of a monolayer prior to treatment or 
exposure. Anakinra (rhIL-1ra) (R&D Systems 280-RA) at 500ng/mL and 1μg/mL and Caspase 1 
inhibitor N-CBZ-Trp-Glu(OMe-His-Asp(OMe) fluoromethyl ketone (Sigma C-1855) at 10 and 
20μM were added to the basolateral compartment in 2%FBS MEM media for 24 h. The next day 
the treatments were refreshed and the cells were exposed to 0.4ppm O3 for 4 h. total RNA was 
collected 1 h post exposure.   
TRIPZ shRNA NLRP2 knockdown in 16HBE cells – NLRP2 shRNA was purchased from 
Life Technologies Dharmacon (RHS5087-EG55655). The vector was grown up in competent 
cells and isolated by the UNC vector core. The lentiviral vectors were added into 16HBE and 
selected for by puromycin at 1μg/mL prior to being maintained or frozen down in LN2. 24 h 
prior to any treatment or exposure the shNLRP2 was activated by 1μg/mL doxycycline and cells 




Statistical Analysis- All in vitro data were performed in at least 3 separate experiments, 
each with multiple technical replicates. Data shown are mean ± SEM. See figure legends for 
further information on the specific statistical analysis used for each experiment. 
 
3.4 Results 
Characterizing the O3-derived oxysterol adductome in 16HBE cells using alkynyl tagged 
Secosterol A (a-SecoA) - In this Chapter, we show that exposure to O3 results in the formation of 
electrophilic oxysterols, which are capable of forming covalent linkages with nucleophilic sites 
in proteins, particularly in lysine residues. While a number of studies, including our own (see 
Chapter 2) demonstrate modification of specific proteins with cholesterol ozonolysis products, 
unbiased analysis of the O3-derived oxysterol-adductome could yield novel targets for 
understanding O3–induced inflammation. The workflow shown in Figure 3.2 shows the shotgun 
proteomics using a tagged alkynyl-secosterolA (a-SecoA) and “click cycloaddition” assay, 
revealing the total inventory of “secosterol-adductomes” in epithelial cells. Streptavidin 
visualization from a small portion of cell lysate showed a host of cellular proteins adducted by a-
SecoA. (Figure 3.2). After streptavidin confirmation of protein adduct formation, the remaining 
lysate was precipitated in cold MeOH to remove excess click reagents. The precipitated and 
washed cell pellets were re-suspended in PBS in the presence of streptavidin beads to pull down 
the adducted proteins and after 2 h, the beads were washed sequentially with SDS, urea, NaCl, 
and ammonium bicarbonate to remove the unbound, and therefore un-adducted, proteins. 
The washed beads were exposed to a small UV lamp (365 nm) for 2 h to release the 
adducted proteins and the freed protein adducts were dried and then re-suspended in LDS buffer 
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followed by a short stacking SDS-PAGE run. The blue stain shows that an array of proteins with 
a broad range of molecular weights had formed adducts with a-SecoA. The stained gels were 
excised followed by in-gel trypsin digestion and the digested peptides were extracted from the 
gel, dried, and reconstituted for MudPIT LC-MS/MS analysis. Experiments were carried out in 
triplicate.  RAW data were searched using MS-GF+beta (V9517) against 
humanRefSeq_Version54 database (Sep 25, 2012; 34589 proteins). Precursor ion mass tolerance 
was 10 ppm, and fragmentation tolerance was 0.01 Da for the database search. The maximum 
number of modifications of 15.9949 Da (Methionine oxidation), + 57.0215 Da 
(Carbamidomethyl alkylation to Cys), + 541.3880 (a-SecoA-triazol-hexanoic acid modification 
to Lys) were searched as dynamic modifications. The maximum Q value of peptide-spectrum 
matches was set as 0.01 using IDPicker software (V. 3.1.9288) that includes 2 minimum spectra 
per protein, and 1 minimum additional peptide.  The IDPicker report was assembled by the mass 
shift 541.3880 Da from the a-SecoA modification shown the structure in Figure 3.3.  We have 
observed that the a-SecoA modified peptides produced diagnostic fragments (DF1 and DF2) m/z 
512 and 129 respectively shown in Figure 3.3. To ensure the accuracy of the identification, all 
modified peptides were manually inspected with the precursor ion accuracy within 10 ppm. After 
manual inspection, 130 unique proteins were recorded to be adducted by a-SecoA. Of these 27 
were associated with cell cycle, 28 with cytoskeletal, 30 with structural proteins, 28 with 
chaperone proteins, and 14 were unique functional proteins. The adducted protein association 
network is shown in Figure 3.5 and the 14 unique functional proteins adducted with SecoA are 
listed in Table 3.1.  
NLR family protein adduction by O3 derived oxysterol SecoA - Of the proteins listed in 
Table 3.1, NLRP2 stands out as the sole adducted protein known to be associated with damage 
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associated molecular patterns like O3. In fact, previous studies have identified patterns of 
inflammasome activity following O3 exposure, primarily driven by NALP family proteins 
(26,27). Of the NALP family proteins, only NLRP2 (NACHT, LRR and PYD domains-
containing Protein 2) was found to be modified by a-SecoA.  A total of 57 peptides belonging to 
NLRP2 (54% coverage) were identified with 218 spectral counts (Figure 3.4C). Lys1019 in the 
sequence of LK*IDDFNDELNK was modified by a-SecoA precursor found m/z 669.0840 (μm 
1.1 ppm) (Figure 3.4A). The b and y ions including the adducted Lys residue are well matched to 
this adduction site. Further the DF1 and DF2 also confirm the modification by SecoA (Figure 
3.4B). 
NLRP2 abundance in various human airway cells - In order to understand the relative 
abundance of NLR family proteins in various primary human airway cells and cell lines, we 
examined the mRNA levels and relative protein abundance of five additional NLR family 
members. Our primary human bronchial epithelial cells (HBECs) as well as human airway 
epithelial cell lines (16HBE, B2B, A549) exhibited significantly higher levels of NLRP2 mRNA 
(Fig. 3.6A-F) and protein (Fig. 3.6G) compared to the other NLR family members measured. 
THP-1 cells, a human blood monocyte cell line, and the K562 cells, a blastoma cell line, are 
known to have high levels of NLRP3 and NLRP1 respectively (28). Our results reflect this 
characterization as the THP-1 cells have significantly more NLRP3 protein and mRNA signal 
while the K562 cells exhibit significantly higher levels of NLRP1 compared to the other 
measured targets. Since NLRP2 is one of the least understood members of the NLR 
inflammasome complex proteins, we confirmed expression and abundance of this protein in a 
variety of cells and tissue. We show for the first time, the high abundance of NLRP2 in human 
primary airway epithelial cells and cell lines, and recapitulate the lower abundance in both 
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monocytic and lymphocytic cell lines previously shown (29,30).  
Confirmation of a-Seco A NLRP2 Adduction by Immunoblotting - Shotgun proteomics 
data revealed that Seco A, a primary ozonide, formed protein adducts with NLRP2. In order to 
validate this finding by targeted immunoblotting assay, a-SecoA was used to “catch and release 
the adducted proteins” as shown in Figure 3.2. In this model, the immunoaffinity purified protein 
with streptavidin beads and photo-released protein mixture were subsequently subjected to 
western blot analyses using antibodies against Histone 3 (HIS3), NLRP2, and NLRP3 (Fig. 3.7). 
HIS 3 is utilized as a known positive control for SecoA adduction, it is a highly conserved 
abundant histone protein subunit that also appears at the top of our list of adducted proteins. 
Input lanes represent the click reaction mixtures and show the equal amount of loaded protein 
between the vehicle control and a-SecoA treated sample. The photoreleased lanes reveal the a-
SecoA adduction of NLRP2 and HIS3 in a-SecoA treated cells and only insignificant amounts of 
proteins in the vehicle control treated cells due to non-specific binding to the Streptavidin beads. 
No such SecoA-NLRP3 adducts were observed in 16HBE cells. For reference, we also tested 
NLRP2 and NLRP3 adduction in THP-1 cells, a monocyte cell line previously reported to 
express high levels of NLRP3 (28). While NLRP3 is present in the THP-1 cells, there is no or 
limited observed adduction by Seco A (Fig 3.7A/E).  
Alkynyl Cholesterol Supplemented Cells Exposed to O3 Reveals the Formation of NLRP2-
adducts - 16HBE cells were grown in the presence of 20μM alkynyl-tagged cholesterol (a-Chol) 
for 6 days. Media containing a-Chol was refreshed daily and the apical side was washed 24h 
prior to O3 exposure. 16HBE cells were exposed to filtered air or 0.4ppm O3 for 4 h and 
harvested 1 h post-exposure. We have previously shown that a-Chol, a surrogate of endogenous 
cholesterol, is incorporated into the cells and, in response to O3, generates a host of alkynyl-
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oxysterols identical to the oxysterol species generated via oxidation of endogenous cholesterol. 
(12) The streptavidin visualization shows that a-Chol incorporated 16HBE cells followed by O3 
exposure exhibit a higher level of overall protein adduction than the air-exposed controls (Fig 
3.7B). Photoreleased proteins were resolved in SDS-PAGE and transferred to nitrocellulose 
membrane and probed with antibodies of NLRP2 and HIS3. Similar to data seen in cells treated 
with a-SecoA shown in Figure 3.7A, NLRP2 and HIS3 were found to be targets of alkynyl-
tagged oxysterols generated endogenously in cells exposed to O3 (Fig 3.7B).  
NLRP2 and Inflammasome Activation in Human Airway Tissues - In order to further 
support our observed prevalence of NLRP2 in human airway epithelial cells, we conducted 
immunohistochemistry analysis for NLRP2 protein and its association with inflammasome 
complex adaptor protein apoptosis associated speck-like protein containing a CARD (ASC) (31). 
Western blot analysis confirms that NLRP2 protein and mRNA levels (Fig. 3.8A,B), as well 
caspase-1 cleavage products are significantly increased in 16HBE cells exposed to O3 compared 
to filtered air (Fig. 3.8B). In 16HBE cells, NLRP2 functions similar to its better known NLR 
family proteins by interacting with caspase-1 activity via the adaptor protein ASC, forming an 
inflammasome complex in order to produce cleaved IL-1β and IL-18. Figure 3.8C shows that 
exposure of 16HBE cells to 0.4ppm O3 for 4 h increased expression of NLRP2 protein and ASC 
independently when compared to cells exposed to filtered air. In the final panel of Figure 3.8A, 
an overlay of the two targets shows an increase in association between NLRP2 and ASC 
following O3 exposure, indicating both that O3 exposure increases inflammasome signaling in 
human airway epithelial cells and that NLRP2-ASC association is a key step in the process.  
NLRP2 Knockdown decreases Inflammatory Signaling - To determine the role of NLRP2 
in O3-induced inflammation, we used lentiviral transduction of NLPR2-specific shRNA to knock 
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down NLRP2 expression in 16HBE cells. The TRIPZ inducible lentiviral shRNA allows the 
vector to be induced specifically in the presence of doxycycline. Our experiments include a 
control exposure of cells that are transduced but the vector remains uninduced with doxycycline. 
Figure 3.9 shows our lentiviral transduction of NLRP2 shRNA significantly reduced NLRP2 
mRNA levels (Fig 3.9A) and protein levels (Fig. 3.9B) to less than 10% of control 16HBE cells. 
In addition, knocking down NLRP2 in 16HBE cells also significantly reduced O3 induced 
markers of inflammation, IL-6 (Fig. 3.10A) and IL-8 (Fig 3.10B) by almost 75% of control 
16HBE cells. These data suggest that reduced NLRP2 in 16HBE cells inhibits NLRP2 
downstream activity necessary for inflammasome activity as well as inhibits the O3 induced pro-
inflammatory signaling response. 
Caspase-1 and IL-1aR inhibitors Blunt O3 Induced Markers of Inflammation - IL-1β and 
IL-18 protein levels in the apical washes or basolateral supernatants were below the limit of 
detection using traditional ELISA methods (data not shown). Therefore, to examine the role of 
NLRP2-mediated inflammasome activation and the role of potential autocrine IL-1 signaling in 
O3-induced expression of IL-6 and IL-8, we used inhibition of caspase-1 and IL-1 signaling. To 
do so, 16HBE cells were treated for 24h with the IL1 receptor antagonist Anakinra or the 
caspase-1 specific inhibitor Z-Trp-Glu(O-Me)-His-Asp(O-Me) fluoromethyl ketone prior to 
exposure to 0.4 O3 or filtered air for 4h. Treatment with both 500ng/mL and 1μg/mL Anakinra 
produced a dose dependent decrease in IL-6 (Fig 3.11A) and IL-8 (Fig 3.11B) expression in the 
O3 exposed 16HBE cells. Similarly, treatment with the caspase-1 inhibitor at 20µM and 40µM 
decreased O3 induced inflammatory cytokine markers in IL-6 (Fig. 3.11A) and IL-8 (Fig. 3.11B). 
Together, these data indicate that caspase-1 and IL-1 dependent signaling mediates O3-induced 





Overall, this chapter describes a new paradigm involving NLRP2-inflammasome 
signaling and O3-induced inflammation in airway epithelial cells. We utilize a convergence of 
existing methodologies and previous studies from multiple fields in order to provide new 
evidence uncovering novel targets of O3-derived oxysterol modification that mediate the well-
described O3 inflammatory response in the human airway. Our unbiased “adductomics” and 
protein analysis identified NLRP2 as a newly relevant and highly abundant protein in human 
airway epithelial cells and a target for O3-derived oxysterol adduction. Our subsequent 
knockdown of NLRP2 confirmed its function in inflammasome complex formation and links O3-
induced NLRP2 adduction and O3-induced inflammation in the lung. In the identified group of 
adducted target proteins, NLRP2 was identified as the sole inflammasome-signaling target 
among mainly abundant structural and cytoskeletal proteins. Overall, our findings introduce and 
delineate a novel signaling pathway linking exposure to O3 and pro-inflammatory responses in 
the human airway. 
Prior to the study described in this manuscript, there was only minimal research reported 
into the prevalence and function of NLRP2 as it pertains to human health, with no publications 
examining its role in the human lung. Our study serves to quantify and describe its role in 
comparison to other NLR family protein species in the airway. Our screening of five of the most 
studied NLR protein family members yielded the surprising result as primary human airway 
epithelial cells and commonly used airway epithelial cell lines presented NLRP2 as the most 
abundant NLR protein at baseline. We strengthen this novel discovery by comparing NLR family 
members in THP-1 and K562 cells, which have higher levels of NLRP3 and NLRP1 
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respectively. This comparison uncovers NLRP2 as a novel target in the human airway epithelium 
with a potential function that may play important roles in airway inflammasome response to 
pathogens and pollutants. Based on our findings, O3-dependent activation of NLRP2 in airway 
epithelial cells appears to result in the formation of an inflammasome complex in a similar 
manner to that described for NLRP3, oligomerizing with ASC and pro-caspase 1. (32). 
Immunohistochemistry analysis in Figure 3.8C shows that expression of NLRP2 is not only 
enhanced but also associates (co-localizes) with the ASC adaptor protein following O3 exposure, 
suggesting increased inflammasome complex formation. Figure 3.8A also demonstrates that O3 
exposure increases caspase-1 cleavage products, additional markers of inflammasome complex 
formation and downstream caspase-1 signaling. To further examine the link between O3, 
inflammasome activation, and pro-inflammatory mediator release, we examined whether the 
expression of IL-6 and IL-8 after O3 exposure is mediated by intermediary IL-1β release, which 
functions in an autocrine/paracrine manner to activate pro-inflammatory gene expression. 
Inhibiting either caspase-1 or the IL-1 receptor also reduces expression of IL-6 and IL-8, 
revealing a probable link between NLRP2 signaling and inflammatory response. In this context, 
our evidence corroborates the requirement for inflammasome activity in O3-induced pro-
inflammatory mediator expression, with the NLRP2 inflammasome complex being a novel 
intermediary step in this process.  
Before considering NLRP2’s prevalence and function, it is useful to consider NLR family 
protein function as a whole. Associations between NLR family protein structure, inflammasome 
activity, and inflammation is mostly conserved and have previously been examined for their 
interaction in the presence of damage associated molecular patterns (DAMPs) and pathogen 
associated molecular patterns (PAMPs) (33-37). Remarkably, the field of NLR protein biology 
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provides some conflicting evidence on their function in inflammation as conformation state and 
isoform of the protein determines whether the NLR protein inhibits or agonizes inflammatory 
signaling (38).  
Specifically, studies in the lung show NLR signaling can greatly vary in response to 
bacterial infection, age related suppression of NLR signaling, and environmental exposures. In 
patients with compromised immune systems, A. baumannii bacteria can activate the host innate 
NLRP3 pathway accounting for uncontrolled inflammation and lung injury (39). Lungs of aged 
mice with suppressed NLRP3 expression and decreased IL-1β production are more prone to S. 
pneumoniae infection. Conversely, NLRP6 deficient mice had enhanced NF-κB activity but 
showed resistance to bacterial infection (40). NLRP3 inhibition also protected mice during 
infection (41). Downstream, caspase-1 inhibitors decreased IL-1β secretion and reduced the 
inflammatory effects of cigarette smoke and diesel exhaust in RAW cells, known to have low 
levels of NLRP2, with upregulated inflammasome activity (29,42). Finally, O3 exposure is 
known to lead to NLRP3 inflammasome activation and IL-1 release in rodent models, 
orchestrating caspase-1 and IL-1 signaling cascade to IL-17A release and neutrophilic airway 
influx (26,27). Based on these varied responses it is critical to understand the constituency of 
NLR proteins in the human airway epithelium and their response to pollutants such as O3. 
In terms of NLRP2, previous studies have reported its capacity as an inhibitor of NF-κB 
activation, enhancing caspase-1 activity in gut, uterine, and immune cells types, however, 
NLRP2 activity in epithelial cells, in the lung, or in the context of O3 exposure is completely 
unknown (29). NLRP2 has been explored as a root cause of inflammasome activity in neuronal 
astrocytes in the human brain, as knock down of NLRP2 in these astrocytes impaired 
inflammasome activation leading to reduced caspase 1 activity (43). Furthermore, a 
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nonfunctional allelic variant of murine NLRP2 in the NACHt domain (I352S) generates a protein 
lacking the NF-κB inhibitory step and exhibits heightened inflammatory stimuli (44). Hence it is 
plausible that oxysterol-induced modification of NLRP2 modifies its ability to regulate NF-kB 
signaling, resulting in enhanced inflammation independent of inflammasome complex formation.  
NLRP2 adduction by O3-derived oxysterols exhibits a new paradigm to be studied in the 
framework of airway inflammation. Many factors impact the sterile inflammation associated 
with O3 inhalation exposure, however few concrete mechanisms linking O3-induced modification 
of biomolecules, like cholesterol, and cellular outcomes, such as increased pro-inflammatory 
mediator expression, have been fully established. Our previous studies have ascertained that 
functional changes to key proteins due to adduction by O3-derived oxysterols can modify 
function and increase inflammatory signaling. NLRP2 abundance and its prevalence as a 
nucleophilic actor in the airway epithelium make it a potentially important target for oxysterol 
adduction and functional modification. In order to study NLRP2 in human airway epithelial 
cells, our analysis combines bioorthagonal cycloaddition chemistry with LC-MS/MS proteomics, 
generating an “adductome” of those proteins in 16HBE cells adducted by ozone derived 
oxysterol Seco A. NLRP2 was identified as adducted at lysine residue K1019 and the sole 
adducted target with potential involvement in O3 induced inflammatory signaling. We 
recapitulate NLRP2 adduction in Figure 3.7 by utilizing the click chemistry reaction and 
immunoprecipitation showing NLRP2 protein is adducted by O3-derived oxysterols. The C-
terminus LRR domain acts as a sensor for DAMPs and PAMPs and initiates the NLR protein 
conformational change for recruitment of the rest of the inflammasome complex proteins 
(45,46). Biochemical analyses indicate that SecoA adduction to NLRP2 occurs in the LRR 
region at lysine K1019 shown in Figure 3.4D. Our data propose that O3-derived oxysterol 
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adduction at this lysine residue in the LRR domain forces the NLRP2 active leaver into a 
constitutively operative position even in the absence of a stimulus. By modifying NLRP2’s 
activation stop-gap, the inhibitory regulation is turned off leading to enhanced inflammasome 
signaling, which was shown by increased caspase-1 activity and inflammasome complex 
formation after O3 exposure. We also observe decreased caspase 1 activity and inflammatory 
signaling overall in cells with knocked down NLRP2 expression, further supporting the notion 
that NLRP2 plays a key role in O3-induced inflammasome activation in airway epithelial cells. 
Lastly, we show that inhibiting the final steps in inflammasome signaling, caspase 1 cleavage 
and IL-1 receptor availability, has the same impact on IL-6 and IL-8 expression as knockdown of 
NLRP2, providing supportive evidence that NLRP2 and inflammasome activity plays a role in 
airway epithelial cell responses to O3.  
Aside from NLRP2, future attention should be paid to the breadth of proteins adducted by 
O3-derived oxysterol Seco A. Within the 130 distinctive proteins adducted only 14 fell outside of 
the gene ontology classifications of structural/cytoskeletal, chaperone, and cell cycle (Table 3.1). 
It is not surprising that the most prominent classifications represented in an unbiased proteomics 
screen are the most abundant proteins in many cell types. In future studies it is important to 
consider the impairment oxysterol adduction may have on these proteins. For example, oxysterol 
adduction to cytoskeletal proteins could alter cell membrane integrity similar to the finding 
presented in previous studies examining oxidized phospholipid adducts in endothelial barrier 
dysfunction (47,48).  
Overall, the data presented within this Chapter serve to link O3-derived oxysterol-NLRP2 
adduction and O3 induced inflammation in the human airway, presenting a new paradigm 
underlying the mechanisms driving the response to O3 exposure. This finding, along with 
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previous NLR protein inflammation studies provide a novel mechanism by which protein 
inflammation may be governed in the human body and specifically identifies NLRP2 as critical 
in airway inflammatory response. Considering the significant abundance of NLRP2 in human 







Figure 3.1: O3-derived oxysterol protein adduction 
Secosterol A (SecoA) and its aldol condensation form Secosterol B (SecoB) derived from 








Figure 3.2: Click Chemistry and LC/MS Analysis 
The treatment of alkyny-secosterol A (a-SecoA) in 16HBE cell line following click reaction to 
introduce biotin for subsequent immune-affinity purification using Streptavidin beads. The 
immobilized proteins onto the beads were washed extensively with various solutions (details in 
the method section) then exposed to hand-held UV lamp (@365 nm) for 2h to release the 
adducted proteins from the beads. The photo-released proteins were dried in SpeedVac and re-
suspended in LDS buffer for short run on SDS-Page LC-MS/MS analysis. (A) a-SecoA adducted 
proteins extended with biotin were probed with IRDye® 800CW Streptavidin. (B) Short stacking 
SDS-Page gel indicates no signs of proteins in the control (DMSO) lane whereas wholesome 




Figure 3.3: Structure of an a-SecoA adduct on a protein lysine after photo-release 
These adducts cause a mass shift of 541.3880 of peptide fragments.  Diagnostic fragments 





Figure 3.4: NLRP2 (NACHT, LRR and PYD domains-containing Protein 2) modification 
with a-SecoA  
(A) Precursor found with an error of 1.1 ppm, (B) MS/MS of the modified peptide and their b 
and y ions assignment including DF1 and DF2. (C) 57 distinctive peptides were also found with 
a total of 218 spectral count. One Lys at the site of 1019 in LRR is modified by a-SecoA. (D) 
NLRP2 structure modeled using cryo-EM structure of NAIP5 from mouse (Mus musculus) with 







Figure 3.5: SecoA Adductome Protein Association Network 
130 SecoA adducted proteins were evaluated by gene ontology and protein association network 
through string-dB. NLRP2 is identified as a unique functional protein adducted and is reported 





Table 3.1: Distinctive SecoA adducted 16HBE proteins  
   
Gene Full name
ACACB Acetyl-CoA carboxylase beta
ALDH1A3
Aldehyde Dehydrogenase 1 family, member 
A3
ALDH5A1
Aldehyde Dehydrogenase 5 family, member 
A1
ATP1B1 ATPase Na/K transporting beta 1 polypeptide
ATP5F1
ATP synthase H+ transporting, mitochondrial 
Fo comples, subunit B
CTPS1 CPT synthase 1
NLRP2 NLR family, pyrin domain containing 2
SLC25A24 Solute carrier family 25 member 24
APEX1 APEX nuclease 1
ARAF A-Raf proto-oncogene, serine/threonine kinase
CCDC59 Coiled-coil domain containing 59
NR2C2AP Nuclear receptor 2C2-associated protein
PARP1 Poly (ADP-ribose) polymerase 1
SRPK3 SRSF protein kinase 3
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Figure 3.6: Relative abundance of NLR family protein and mRNA in human airway 
epithelial cells 
Various primary and immortalized human airway epithelial cells, along with other reference cells 
types, were harvested for total RNA and whole cell lysate for evaluation via qPCR and 
immunoblot analysis of NLR family proteins. Cells were exposed to filtered air or 0.4 ppm 
ozone for 4 h and samples were collected 1 h post-exposure. Gene expression levels of NLRP1, 
NLRP2, NLRP3, NLRP7, and NLRP12 were evaluated in (A) 16HBE, (B) primary HBEC, (C) 
A549, (D) B2B, (E) THP-1, and (F) K562 cells. Additionally, protein levels for NLRP1, NLRP2, 
and NLRP3 were evaluated in all the aforementioned cell type by (G) immunoblot. Data are 
presented as mean ± SEM. Statistical analysis was performed with a one-way ANOVA and 
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Figure 3.7: Protein catch and photo-release using a-Seco A and a-cholesterol in 16 HBE 
and THP-1 cells 
(A) 20 μM a-SecoA was added in 16HBE cells and THP-1 cells for 4 h and harvested for click 
and photo-elution. Click mixture was loaded in INPUT serve as control loadings. No signs of 
NLRP2/3 and HIS3 adductions in DMSO lanes for both cell lines is shown after photo-elution. 
Only a-SA treated cells were adducted, captured by streptavidin, and photo-released. Abundant 
levels of NLRP2 is present but not NLRP3 in 16HBE cell line (INPUT) whereas significant 
levels of NLRP3 but not NLRP2 in THP-1 cell line (INPUT). Interestingly, no NLRP3 adduction 
is observed in THP-1 cells even if the cells were treated with 20 μM a-SecoA indicating SecoA 
adduction is highly specific to the protein environment.  (B) 16HBE cells were grown in the 
presence of 20 μM a-Chol prior to ozone exposure. This is true representation of endogenous 
oxysterols generation and their concentrations when exposed to ozone. Proteins were adducted 
by alkynylated oxysterols, captured, and photo-released (ELUTED). (C-E) Recapitulated 
findings utilizing fluorescent probes on additional samples NLRP2 (anti-mouse) is conjugated 
with IRDye800CW (green) and NLRP3 (anti-rabbit) is conjugated with AlexaFluor680 (red). 
Indeed the NLRP2 and HIS3 are the targets of the endogenous oxysterols, suggestively alkynyl-





Figure 3.8: Immunohistochemistry and immunoblot analysis of O3 induced levels of 
NLRP2 and inflammasome activity in human airway epithelial cells 
A) Representative blot of NLRP2 and Caspase-1 and its cleavage products in whole cell lysate 
collected 1 h post-exposure from 16HBE cells exposed to filtered air or 0.4ppm ozone for 4h. B) 
Relative densitometry of NLRP2 from three separate immunoblot experiments. Data are 
presented as mean ± SEM. Statistical analysis was performed with a one-way ANOVA and 
Fisher’s LSD post hoc test comparing observed means between filtered air and 0.4ppm O3 
*p<0.05, n=3. C) HBECs exposed to air/ O3 were immunohistochemically stained for DNA 






Figure 3.9: shRNA knockdown of NLRP2 in 16HBE cells  
A) qPCR measurements of NLRP2 knockdown in 16HBE cells. B) Immunoblot confirmation of 
shNLRP2 knockdown in 16HBE cells, a representative blot.  Data are presented as mean ± SEM. 
Statistical analysis was performed with a one-way ANOVA and Fisher’s LSD post hoc test 






Figure 3.10: NLRP2 shRNA inhibits O3-induced inflammatory signaling  
A) IL6 and B) IL8 gene expression in control and shNLRP2 16HBE cells exposed to 0.4ppm O3 
for 4 h and harvested 1 h post. Data are presented as mean ± SEM of fold change compared to 
the DMSO control. Statistical analysis was performed with a one way ANOVA and Fisher’s 
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Figure 3.11: Anakinra and Cas-1 inhibitors also inhibit inflammatory signaling in 16HBE 
cells. 
A) IL6 and B) IL8 gene expression in 16HBE cells treated with Anakinra at 500ng/ml or 1μg/ml 
and Caspase-1 inhibitor at 10μM and 20μM for 24 h. The cells were then exposed to filtered air 
or 0.4ppm O3 for 4h and total RNA collected 1 h post-exposure. Data are presented as mean ± 
SEM of fold change “&” indicates comparison to the DMSO control. Statistical analysis was 
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CHAPTER 4: THE SMALL MOLECULE ANTIPSYCHOTIC ARIPIPRAZOLE 
POTENTIATES OZONE-INDUCED INFLAMMATION IN AIRWAY EPITHELIUM 
4.1 Overview 
Inhaled ground level ozone (O3) has well described adverse health effects, which may be 
augmented in susceptible populations. While conditions, such as pre-existing respiratory disease, 
have been identified as factors enhancing susceptibility to O3-induced health effects, the 
potential for drug x pollutant interactions in sensitizing populations or further exacerbating 
underlying conditions has not yet been studied. In the airways, inhaled O3 is able to interact with 
the lipid rich airway lining to generate reactive and electrophilic oxysterol species capable of 
causing cellular dysfunction and inflammation. Therefore, drugs that modify cholesterol 
synthesis could have a deleterious biological effect in the presence of O3.  Chemical analysis 
studies have established the capacity for a variety of small molecule antipsychotic drugs, like 
Aripiprazole (APZ), to elevate circulating 7-dehydrocholesterol (7-DHC) levels by competitively 
inhibiting 7-dehydrocholesterol reductase, the enzyme regulating the final step of cholesterol 
biosynthesis. 7-DHC serves as a highly reactive target for lipid peroxidation and increased 
oxidative stress. Our results show that APZ, administered at clinically relevant concentrations, 
and the known DHCR7 inhibitor, AY9944, increase 7-DHC levels and potentiate O3-induced 
pro-inflammatory cytokine expression and alter overall gene expression in airway epithelial 
cells. Additionally, we find that ozonized 7-DHC enhances IL-6 and IL-8 expression to a greater 
extent than ozonized cholesterol. Overall, the evidence we provide describes a potential 
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mechanistic basis for a drug x pollutant interaction between APZ and O3, posing significant 
adverse public health implications considering the prevalence of O3 exposure and APZ use. 
  
4.2 Introduction 
According to the World Health Organization, total global air pollution increased 8% 
between 2011 and 2016, with more than 80% of people living in developed urban settings 
exceeding WHO air quality guidelines (1). Concurrently, the development of small-molecule 
pharmaceutical drugs, including antidepressants, has increased exponentially over the last 20 
years. In the United States, 59% of the population is taking one or more pharmaceutical drugs 
and of those people, antidepressant use doubled from 6.8% to 13% between 1999-2012 (2,3). 
Combined, the pervasive issue of global air pollution and the steady increase of pharmaceutical 
drug use provides an ever-growing opportunity for biochemical interaction and potential for 
adverse health effects. Despite the capacity for drugs to biochemically alter the targets for 
pollutants and potentially exacerbate injury, little research has been conducted on drug x 
pollutant interactions and human health. 
While there are limited well-described drug x environment interactions, such as 
antibiotic-induced UV photosensitivity by Tetracycline (4-6), even fewer studies have examined 
this concept in the context of air pollution. Previous studies have demonstrated that in mice, 
ozone (O3) exposure potentiates liver injury caused by supratherapeutic acetaminophen doses. 
Similarly, acetaminophen exacerbates environmental tobacco smoke-induced oxidative stress 
and sensory irritant-reflex responses in rodent models (7,8). However, the inflammatory potential 
of other drug x pollutant interactions in the human lung remains completely unknown. This is 
particularly important for ambient pollutants, such as O3, as currently more than a third of the 
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U.S. population lives in areas exceeding the 2015 National Ambient Air Quality Standard for O3 
(0.07ppm for 8-hour average), which are exposure levels known to decrease lung function and 
cause inflammatory responses in humans (9-11).  
O3 is a highly reactive oxidant gas, capable of damaging organic molecules in human 
tissue. More specifically, O3 reacts with pulmonary surfactant and epithelial cell membranes to 
produce lipid peroxides and oxidant species (12). In the airway, O3-induced oxidation of 
cholesterol is known to lead to the formation of electrophilic oxysterols, capable of forming 
protein adducts, potentially perturbing normal cellular signaling, and increasing inflammation 
(13-15)). Therefore, drugs that alter cholesterol synthesis could potentially modulate O3-induced 
inflammation in the lung. Indeed, epidemiological data indicates that cholesterol-modifying 
drugs, such as statins, mitigate oxidant stress and air pollutant-induced adverse health effects, 
yet, little clinical evidence has been presented specifically for O3 (16,17). More importantly, 
limited research has examined the potential for other cholesterol-modifying drugs to exacerbate 
O3-induced health effects (18,19).  
In particular, one of the final steps in the synthesis of cholesterol involves the reduction 
of 7-dehydrocholesterol (7-DHC) to cholesterol by the enzyme 7-dehydrocholesterol reductase 
(DHCR7) as illustrated in Figure 4.1A. 7-DHC contains two double bonds on the primary carbon 
ring (Fig 4.1B/C), making it highly susceptible to O3-induced oxidation and lipid peroxidation 
chain propagation (20). Considering the high ozonization potential of this sterol, any cell or fluid 
with elevated levels of 7-DHC could be sensitized to O3-induced oxidative stress (21). Therefore, 
the effects of drugs which modify cholesterol synthesis by elevating the 7-DHC/Cholesterol ratio 




In 2014, the small molecule antipsychotic drug Abilify®, common name: aripiprazole 
(APZ), often prescribed for off-label use as an anti-depressant or for anxiety, accounted for 8 
billion dollars in sales and was ranked 2nd in the U.S. for top selling prescription drugs (22). 
Notably, APZ inhibits DHCR7 activity in an off-target effect, thereby modifying cholesterol 
metabolism and leading to accumulation of 7-DHC (23,24). However, whether drugs, such as 
APZ, known to modify cholesterol synthesis and lead to the accumulation of reactive cholesterol 
precursors, could potentially exacerbate O3-induced inflammation, presents a clinically important 
knowledge gap. Thus far, the potential for drug x pollutant interactions to sensitize populations 
to ground level O3 has not yet been studied (25). The increased prevalence of O3 air pollution 
and use of prescription small molecule drugs, such as APZ, further illuminates the scope and 
capacity for drug x pollutant interaction leading to adverse health outcomes. Our study is 
designed to elucidate the impact of the cholesterol-modifying drug APZ on O3-induced 
inflammation in the human airway. We hypothesize that APZ inhibition of DHCR7 increases 
pulmonary levels of 7-DHC, leading to the formation of highly reactive oxysterol species and 
potentiation of O3-induced inflammation. 
 
4.3 Materials and Methods 
Cell Culture – 16HBE14o (16HBE) cells, a SV-40 transformed human bronchial 
epithelial cell line were a gift from Dr. D. C. Gruenert (University of California San Francisco, 
San Francisco, CA). For experiments performed at air-liquid interface (ALI), 16HBE cells were 
plated on fibronectin-coated (LHC Basal Medium [Life Technologies, Carlsbad, CA], 0.01% 
Bovine serum albumin (BSA) [Sigma-Aldrich, St. Louis, MO], 1% Vitricol [Advanced Bio 
Matrix, San Diego, CA], and 1% human fibronectin  [BD Biosciences, San Jose, CA]) 0.4µm 
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Transwell® plates (Costar, Corning, NY), and grown submerged in minimal essential media 
(MEM) (Gibco, Thermo Fisher, Gaithersburg, MD) with 10% fetal bovine serum (FBS) (Gibco), 
1% penicillin-streptomycin (Gibco), and 1% L-glutamine (Gibco) until confluent for 6 days. For 
experiments performed with submerged cultures, 16HBEs were plated on fibronectin coated 12 
or 24 well plates and given 10% FBS in MEM. For both types of in vitro experiments, the serum 
concentration was reduced to 2% FBS, apical media was removed (if at ALI), and the cells were 
grown for an additional day before treatment and subsequent challenges.  
Pharmaceutical drug treatment of 16HBE cells – APZ (Sigma-Aldrich) and AY9944 
(Sigma-Aldrich) were reconstituted in DMSO to create a 10mM stock solution. Submerged cells 
were given 1mL and 500µL of 1μM APZ treatment for 12 and 24 well plates, respectively. Drug 
treatments were replenished daily and immediately before O3 exposure. Treatment of cells with 
AY9944 was completed in a similar fashion at concentrations of 0.5µM and 1µM. 
TNF agonist treatment – Submerged 16HBE cells were grown in 24 well plates until 
confluent and given 500µL of 1µM of APZ in 2% FBS MEM. TNF was reconstituted in DPBS 
(Gibco) to create a 10µg/mL stock solution; serial dilutions were performed in 2% FBS MEM to 
make a 20ng/mL solution. After 3 days of pre-treatment with APZ, cells were stimulated with 
TNF for 4hrs. Immediately afterwards, RNA was collected for qPCR analysis. 
Ozonization of sterols in solution – Compressed Gas, Oxidizing, N.O.S. (oxygen, Nitrous 
Oxide) (UN3156, Airgas USA, Radnor, PA) was sent through an ozone generator (AquaZone, 
Red Sea, Huston, TX) and bubbled through Hanks’ balanced salt solution with calcium and 
magnesium (HBSS++) (Life Technologies) containing either 20µM cholesterol (Sigma-Aldrich), 
7-DHC (Sigma-Aldrich), or DMSO for 30mins. Solutions were immediately applied to 
submerged 16HBE cultures for 1hr. Solutions not sent through the compressed gas and ozone 
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generator were also applied directly to cells as a control. Afterwards, RNA lysates were collected 
and analyzed for IL-6 and IL-8 expression. 
In Vitro O3 Exposure – Cultured 16HBE cells at ALI were exposed to either filtered air or 
0.4ppm O3 for 4hrs in exposure chambers operated by the U.S. EPA in order to mimic the 8hr 
average exposure of an individual. This dose of O3 is shown to have minimal cytotoxicity and 
maximal innate immune response in our 16HBE cells (26). 1hr post exposure, basolateral media 
was collected, apical sides of the transwells were washed with 110µL of Hanks’ balanced salt 
solution (HBSS) (Life Technologies). RNA was collected in lysis buffer provided by the Pure 
Link RNA Mini Kit (Life Technologies, Carlsbad, CA) prepared with 1% 2-Mercaptoethanol 
(Sigma-Aldrich). 
Real-time qPCR – Total RNA was isolated from the 16HBE lysates using the RNA kit 
listed above. cDNA preparation and real-time qPCR were performed as previously described 
(27,28). The β-actin primer was purchased from Applied Biosystems, Foster City, CA. Human 
IL-8: 5’-FAM-CCTTGGCAAAACTGCACCTTCAC-TAMRA-3’ (probe), 5’-
TTGGCAGCCTTCCTGATTTC-3’ (sense), and 5’-
TATGCACTGACATCTAAGTTCTTTAGCA-3’ (antisense) and IL-6: 5’-FAM-
CCAGCATCAGTCCCAAGAAGGCAACT-TAMRA-3’ (probe), 5’-
TATGAAGTTCCTCTCTGCAAGAGA-3’ (sense), and 5’-TAGGGAAGGCCGTGGTT-3’ 
(antisense) were prepared in-house. Expression was determined by the ΔΔCt method using β-
actin for normalization. ΔCt values were computed by subtracting the threshold cycle (Ct) values 
for β-actin from the Ct values for the gene of interest. The ΔCt for the control was then 
subtracted from each sample’s value to determine the ΔΔCt values. The fold change in gene 
expression was then calculated as 2-ΔΔCt. 
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NanoString Gene Expression Analysis – 16HBE mRNA was isolated from samples 
obtained from cells exposed to 1μM ApZ for 3 days followed by 4 h O3 exposure and analyzed 
for gene expression via Nanostring™ (Seattle, WA) nCounter® PanCancer Immune Profiling 
Panel. Nanostring™ gene expression data were normalized to the geometric mean of stable 
housekeeping genes and to positive and negative control genes, and analyzed using the 
nSolver™ software provided by the manufacturer.  The heat map was generated using Average 
Pearson Correlation and unbiased clustering. 
Statistical Analysis – All in vitro data were performed in at least 3 separate experiments, 
each with multiple technical replicates. Data shown are mean ± SEM. See figure legends for 
further information on the specific statistical analysis used for each experiment. 
LC-MS/MS 7-DHC measurement – Samples were chromatographed by RP-HPLC using a 
UPLC BEH C18 column (1.7μm, 2.1mm × 100mm) in Waters Acquity UPLC system equipped 
with an autosampler (Waters, Milford, MA) and either ESI or APCI in positive ion mode. For 
ESI, the sterols were separated by 95% 2mM NH4OAc in MeOH (solvent B) in an isocratic 
method with a flow rate of 200µL/min, and the mobile phase solvents consisted of 2mM 
NH4OAc (solvent A) in water and solvent B. The injection volume was 10μL using a partial loop 
with needle overfill mode. MS detections were done using a TSQ Quantum Ultra tandem mass 
spectrometer (ThermoFisher, Waltham, MA), and data was acquired and analyzed using a 
Thermo Xcalibur™ 2.2 software package. 
 
4.4 Results 
APZ and AY9944 increase 7-DHC levels in human airway epithelial cells – Our 
experimental paradigm treated 16HBE cells with increasing concentrations of APZ or the known 
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DHCR7 antagonist AY9944 for 1 or 3 days. No morphological changes were observed at any 
concentration, and our 1µM APZ treatment regimen showed no overt cytotoxicity after 1, 3, or 
6d of treatment (Fig. 4.2A). We also quantified the level of 7-DHC in 16HBE cells treated with 
APZ. Although the 1 day treatments of APZ increased the 7-DHC/Cholesterol ratio, the 3 day 
1µM APZ treatment yielded the greatest significant increase in 7-DHC/Cholesterol to a near 1:1 
ratio compared to a neglidgable ratio at baseline (Fig. 4.2B). The known DHCR7 antagonist 
AY9944 also altered sterol levels in an almost identical manner, significantly increasing the 7-
DHC/cholesterol ratio to 1 (Fig. 4.2B). Notably, the 7-DHC to cholesterol ratio in both treatment 
groups was decreased in cells exposed to O3, perhaps indicating the conversion of 7-DHC into 7-
DHC-derived oxysterols. 
APZ treatment causes O3-specific increases in pro-inflammatory cytokine levels – As 
shown in previous studies, exposure to O3 causes an inflammatory response in 16HBE cells 
marked by significant increases in the gene expression of pro-inflammatory cytokines IL-6 and 
IL-8 (Fig. 4.3A-F). APZ treatment with 1µM for 1, 3, and 6 days prior to O3 exposure 
significantly potentiated IL-6 and IL-8 expression 1.5 to 2 times higher when compared to 
vehicle (0.01% DMSO) treated cells exposed to O3 (Fig. 4.3A/B). Protein concentrations of these 
cytokines followed the same trend, but did not yield significant differences between the APZ and 
DMSO treated cells in the O3 exposure group (Fig. 4.3C/D). Treatment with the DHCR7 
inhibitor AY9944 similarly increased pro-inflammatory IL6 and IL8 levels in O3 exposed 16HBE 
cells (Fig. 4.3E/F). Notably, treatment with APZ for any duration did not significantly increase 
pro-inflammatory cytokine levels when exposed to filtered air. Moreover, the APZ-induced 
potentiation appears to be O3 specific as 16HBE cells challenged with another NF-B agonist, 
TNFα, did not exhibit the same APZ-exacerbated expression of IL-6 and IL-8 (Fig. 4.4A-B).  
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Nanostring gene expression analysis of APZ and O3 – Using the NanoString nCounter® 
PanCancer Immune Profiling Panel, 16HBEs treated for 3 days with 1µM of APZ or DMSO and 
exposed to air or O3 were examined for 730 genes, of which 409 were detectable at baseline in 
our DMSO/Air exposed cells. O3 exposure alone revealed 222 genes with significantly altered 
expression. Within the O3 exposed cells, APZ treatment showed 45 genes with altered expression 
when compared to the DMSO treated cells (Fig. 4.5A). Of these 45 genes, 18 were upregulated 
(Table 4.1) and 27 were downregulated (Table 4.2) compared to APZ pre-treatment. Two-thirds 
of the upregulated genes are involved in defense response and/or regulation of defense response 
(String-db GO:0006952 and String-db GO:0031347). Additionally, of the 18 upregulated genes, 
14 were identified in their involvement in cellular response to stimulus (GO:0051716) (Fig. 
4.5B). Functions varied within the 27 downregulated genes, as 9 of the 27 downregulated were 
associated with macrophage and lymphocyte recruitment, maturation, and inflammation 
resolution (Fig 4.5C).  
Ozonized 7-DHC increases expression of inflammatory cytokines – O3 was bubbled 
through HBSS++ buffer with vehicle DMSO, or with 20µM cholesterol, or 7-DHC for 30 
minutes. Buffer solutions were immediately added to submerged 16HBE cultures for 1 h, which 
were subsequently analyzed for IL-6 and IL-8 expression. In comparison to the DMSO control, 
cells treated with buffer containing ozonized cholesterol modestly elevated IL-8 expression and 
significantly elevated IL-6 expression. However, buffer containing ozonized 7-DHC significantly 
increased IL-6 and IL-8 expression to a greater extent in comparison to ozonized DMSO (Fig. 
4.6A-B). Remarkably, there was also a moderately convincing increase in IL-8 expression in 
ozonized 7-DHC compared to ozonized cholesterol (p ≤ 0.075). No significant changes in IL-6 or 






The increasing prevalence of both pharmaceutical drug use and environmental pollutants 
in the developed world highlight the need to study their potential interactions and combined 
effects. In order to fill this knowledge gap, we explored the impact that drugs with DHCR7 
inhibitory effects may have on O3 induced inflammatory response in human airway epithelial 
cells. We observed that APZ, a known DHCR7 inhibitor, significantly increased O3-induced pro-
inflammatory cytokine expression and elevated the 7-DHC to cholesterol ratio. Further 
supporting this finding, ozonization of buffer containing 7-DHC significantly enhanced the 
ability to increase the expression of IL-6 and IL-8 to a greater extent than ozonized cholesterol 
did (Figure 4.6). Taken together, these data provide a mechanistic basis for a drug x pollutant 
interaction and drug-induced augmentation of O3-induced adverse health effects. 
As we describe above, APZ and similar small molecule drugs commonly prescribed for 
depression are widely used in the US with nearly 10 million prescriptions filled annually (22,29).  
While APZ is designated an antipsychotic, only 2.5% of the U.S. population are diagnosed as 
such and it is commonly prescribed in combination with other drugs to treat depression, tic 
disorders, and irritability associated with autism (30). Circulating levels can reach up to 0.7μM 
levels in patients with severe bipolar and schizophrenic disorder, informing our use of 1µM as 
physiologically relevant (31,32). Our data demonstrate that APZ treatment intensifies the well-
described O3-induced inflammation in human airway epithelial cells (33,34). In Figure 4.3, APZ 
treatment regimens at 1µM over 3 days significantly increased O3-induced inflammatory 
cytokine expression almost 2-fold over the vehicle treated cell response to O3. We did not 
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observe a significant change in IL-6 or IL-8 at the protein level in Figure 4.3C and D. This 
discrepancy is likely due to the timing of collection and further studies over longer time points 
are necessary. Our broad gene expression array data suggest that, in addition to increased IL-6 
and IL-8, APZ treatment diminished O3-induced expression of MIF, S100A12, MICA, and 
IFNAR1, all genes associated with immune defense response when compared to the DMSO 
control treatment. In total, APZ treatment altered O3 response expression in 44 genes listed in 
tables 4.1 and 4.2. These data suggest that individuals taking Abilify® on high air pollution days 
could be susceptible to increased inflammatory responses or adverse conditions in the airway.  
More broadly, pharmaceuticals with unknown modes of action or side effects could lead to 
interaction with environmental exposures and unintended adverse outcomes. 
It should be noted that APZ treatment may have impacts on the airway aside from 
potentiating O3-induced inflammation. The Nanostring array data shown in Figure 4.5 show that 
APZ treatment has the potential to alter O3-induced 16HBE gene expression, which may have an 
independent impact on airway health. For example, the highest observed fold change increase in 
gene expression following APZ treatment compared to DMSO was in the integrin subunit alpha 
1 (ITGA1) by 1.4 fold. An increase in ITGA1, which is known to be associated with cell-cell 
adhesion and inflammatory signaling and could also contribute to the sterile neutrophil influx 
and immune cell dysfunction associated with O3 exposure (35). Additionally, the array data and 
protein association networks in Figure 4.5C show that cells pre-treated with APZ prior to O3 
exposure experienced significant decreases in the expression of various defense innate immune 
responses. Notably, MAPK11, TP53, and HRAS are all down regulated. Alterations in the 
expression of these genes could result in serious dysfunction of the important cell proliferation 
and survival MAPK/ERK pathway. Although we see an increase in IL-6 and IL-8 transcription 
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after APZ treatment, our gene expression panel and association network in Figure 4.5B/C also 
reveals a significant decrease in inflammatory mediator expression. Notably, MYD88 expression, 
an IL-1 receptor signaling pathway protein that leads to NF-κB activation and enhanced IL-8 
formation is downregulated following APZ treatment. Conversely, NF-κB2 and TNF are 
reported as significantly up regulated in APZ alone treated cells. Ultimately, the APZ-x-O3 
interaction leads to a varied gene expression response and may serve to magnify the adverse 
health outcomes associated with inflammatory response and host defense response. 
Although the airways are not a significant contributor to the production of endogenous 
cholesterol, our previous studies show that exposure to O3 significantly increases the levels of 
electrophilic oxysterols formed in the healthy human airway compared to individuals exposed to 
only filtered air (13). 7-DHC represents a unique target for ozonization as the additional double 
bond at C7 makes the molecule oxidatively unstable, allowing the molecule to be highly reactive 
towards free radical oxidation and one of the best chain-carrying molecules studied to date (36-
38). Any alteration in cholesterol homeostasis and an increase in available 7-DHC could lead to 
the creation of highly reactive oxysterol species. The drug APZ is a known inhibitor of DHCR7, 
and increases the 7-DHC/cholesterol ratio in various human cell types (15,39), including airway 
epithelial cells, as shown in data presented here (Figure 4.2B). The oxidized lipids formed due to 
7-DHC ozonizaton are different than those formed due to cholesterol ozonization and have the 
potential to be more electrophilic and more rapidly react with available proteins and cellular 
components. The electrophilic oxysterol species structure determines its reactivity with cellular 
components, thus, it is important to consider any drug-induced modulation to available sterol 
content in the airway and the potential to generate oxysterol species. We concede that isolation 
and measurement of 7-DHC ozonization products in human airway epithelial cells treated with 
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APZ would benefit our model greatly. However, the product mixture from 7-DHC ozonization is 
extremely complex and stable primary products have not yet been unambiguously assigned (Dr. 
Ned Porter; personal communication), which is a limitation of this study.  
Due to this limitation, we aimed to link the potential for APZ to inhibit DHCR7 and 
increase the ratio of 7-DHC/cholesterol in airway epithelial cells as the primary mechanism for 
the potentiated O3 effect. Although we cannot present direct evidence of DHCR7 inhibition by 
APZ in 16HBE cells, it has been shown previously in Neuro2A cells (24,39), and we show here 
that APZ significantly increases levels of 7-DHC in human airway epithelial (Figure 4.2B). 
Additionally, use of the commercially available DHCR7 inhibitor AY9944 provided a tool to 
examine the effects of DHCR7 inhibition on O3-induced inflammation. Similar to APZ, AY9944 
increased the 7-DHC/cholesterol ratio and potentiated O3 induced inflammatory effects in 
16HBE cells. The similar effects of AY9944 and APZ on 7-DHC/cholesterol ratio, support our 
hypothesis that APZ inhibition of DHCR7 and increased abundance of 7-DHC mediates the 
potentiation of O3 induced inflammation. 
In order to link 7-DHC ozonization products with enhanced inflammatory gene 
expression without the ability to directly measure the reactive byproducts, we conducted 
experiments directly stimulating cells with ozonized sterols derived from either 7-DHC or 
cholesterol. As shown in Figure 4.6, our data demonstrate that the ozonized 7-DHC products 
significantly enhance IL-6 and IL-8 expression more than ozonized cholesterol products. We also 
show the ability of APZ to enhance markers of inflammation is specific to O3 exposure. 
Specifically, IL-6 and IL-8 expression in16HBE cells exposed to TNF-α were not affected by 
APZ (Fig 4.4), indicating that the effects of APZ-induced enhancement of IL-6 and IL-8 
expression are not generally applicable to all pro-inflammatory stimuli, but to specific to 
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oxidants, such as O3. Together, these data suggest that the more reactive oxysterol species 
derived from the ozonization of 7-DHC recapitulated the increased inflammatory responses seen 
in O3-exposed 16HBE cells treated with APZ.  
Our study highlights the consequence of drug induced cholesterol modification in the 
presence of oxidant pollutants. Aside from APZ, different classes of therapeutic drugs have the 
potential for off-target cholesterol modification including other small molecule anti-depressants, 
and β-blockers. Our investigative team is in the process of extensively examining the potential 
for various pharmaceutical drugs to inhibit steps in cholesterol synthesis, enhancing the 
formation of 7-DHC (24). Table 4.3 highlights a few drugs that are among both the highest 
potency for DHCR7 inhibition in Neuro2A cells and frequency prescribed in the U.S. population. 
This analysis indicates that the effects of drugs modifying DHCR7 activity and O3-induced 
inflammation are not limited to small molecule antidepressants, such as APZ, but also include 
other classes of commonly prescribed drugs. Specifically, we propose future studies to look at 
widely prescribed drugs known to inhibit DHCR7 and their influence on O3 induced 
inflammation. These data underscore the need for additional comprehensive screening of 




Overall, our research findings support the hypothesis that APZ-induced inhibition of 
DHCR7 and subsequently elevated 7-DHC levels potentiate O3-induced inflammation in the 
human airway.  These findings also describe a previously unknown drug x pollutant interaction.  
While there are a limited number of previously described drug x pollutant interactions, we 
believe our findings are indicative of a larger number of potential interactions that have yet to be 
uncovered. With ever increasing use of pharmaceutical prescription and ubiquitous air pollution 
globally, there is a clear need for a new paradigm in toxicity testing examining drugs with the 
potential to enhance pollutant-induced health effects. 






Figure 4.1: APZ inhibition of cholesterol synthesis pathway, 7-DHC and cholesterol 
structures  
(A) Cholesterol synthesis pathway and impact of APZ on DHCR7. (B) Chemical structure of 






Figure 4.2: APZ and AY9944 effects on 7-DHC levels in airway epithelial cells 
(A) LDH release assay demonstrated no overt cytotoxicity at 1µM APZ for 1 and 3. LC-MS/MS 
analysis revealed an increase in the ratio of 7-DHC to cholesterol in 16HBE cells grown at ALI, 
given (B) 1µM APZ or (C) AY9944 for 3 days compared to 1 day. n=4-8 for (A) and n=3 for 
(B). Data are presented as mean ± SEM. Statistical analysis was performed using a one-way 
ANOVA for (A) and a two-way ANOVA for (B). *p≤0.05, ****p≤0.00001 compared to 
respective DMSO control treatment. 
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Figure 4.3: APZ potentiates O3-induced IL-6 and IL-8 expression 
16HBE cells grown at ALI treated basolaterally with 1µM concentration of APZ 1d, 3d, and 6d 
prior to 0.4ppm O3 exposure yielded enhanced expression of (A) IL-6 and (B) IL-8 with 
significance increases in both markers after 3d APZ treatment. Prolonged APZ treatment prior to 
O3 exposure also increased (C) IL-6 and (D) IL-8 protein levels. Treatment with 0.5µM and 1µM 
AY9944 for 3d enhanced (E) IL-6 and (F) IL-8 expression. (A-B) n=3-5, (C-E) n=3. Data are 
presented as mean ± SEM. Statistical analysis was performed using a two-way ANOVA. 
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Figure 4.4. Stimulation with TNF does not incite APZ-induced IL-6 and IL-8 expression. 
Treatment with 1µM APZ or AY9944 for 3d followed by 20ng/mL TNFα treatment for 4h did 
not potentiate the any change in O3-induced (A) IL-6 and (B) IL-8 expression, n=4. Data are 
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Figure 4.5. Nanostring analysis of gene expression in 16HBE cells treated with APZ  
(A) Unbiased heat map of gene expression for cells exposed to O3. Cells treated with DMSO and 
cells treated with 1µM APZ for 3d resulted in distinct gene expression profiles. Significantly (B) 
upregulated and (C) downregulated expression of genes in APZ treated cells exposed to O3 
compared to the O3 exposed vehicle control. Upregulated genes involved in defense response are 
shaded red (GO:0006952) and genes involved in the regulation of defense response are shaded 
blue (GO:0031347) in (B). Down regulated genes involved in cellular response to stimulus are 
shaded red in (C). n=3. Genes in (A-C) identified using a paired, two tailed t-test comparing O3 





Table 4.1. APZ upregulated genes after O3 exposure. Significantly upregulated genes 
organized by p value. Mean ± SEM. Paired two tailed t-test. 
  
Gene DMSO/O3 Count APZ/O3 Count p-value 
EBI3 52.43 ± 5.51 66.45 ± 5.91 0.00104 
STAT1 2722.07 ± 135.98 3002.31 ± 132.24 0.00141 
KIR3DL1 34.50 ± 5.09 37.61 ± 4.97 0.00329 
IGF2R 689.89 ± 12.07 863.15 ± 27.85 0.00866 
SMAD2 1790.46 ± 72.88 1851.71 ± 79.48 0.01201 
NOTCH1 343.62 ± 27.12 401.25 ± 22.16 0.01220 
NFATC2 922.61 ± 130.38 1025.80 ± 134.32 0.01246 
TNF 1563.69 ± 59.08 1755.18 ± 36.17 0.01585 
MME 585.77 ± 99.67 701.65 ± 106.51 0.02065 
CYFIP2 77.12 ± 3.49 85.24 ± 4.71 0.02214 
ITGA1 58.81 ± 6.77 82.14 ± 3.31 0.02265 
IFNB1 172.72 ± 24.86 214.98 ± 29.02 0.02592 
CD68 182.82 ± 24.42 214.30 ± 28.14 0.02725 
NFATC4 45.36 ± 5.04 49.01 ± 4.51 0.02890 
NFKB2 2647.99 ± 188.55 2808.19 ± 171.01 0.03151 
TNFRSF10C 91.86 ± 10.78 112.77 ± 10.62 0.03499 
REPS1 1502.32 ± 3.02 1633.30 ± 25.90 0.04145 
C4B 22.33 ± 3.02 28.33 ± 2.63 0.04545 
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Table 4.2. APZ downregulated genes after O3 exposure. Significantly down regulated genes 
organized by p value. Mean ± SEM. Paired two tailed t-test. 
 
Gene DMSO/O3 Count APZ/O3 Count p-value 
PSMB10 1850.21 ± 129.37 1659.82 ± 136.52 0.00142 
HRAS 724.77 ± 22.48 620.90 ± 27.38 0.00324 
CD81 6198.99 ± 107.31 5886.74 ± 88.93 0.00400 
CD164 8218.67 ± 232.19 8013.24 ± 218.99 0.00427 
MIF 15623.29 ± 751.64 12323.69 ± 744.10 0.00744 
IFNAR1 562.88 ± 17.11 482.03 ± 10.01 0.00851 
F2RL1 2726.62 ± 248.21 2519.25 ± 253.95 0.00863 
CD55 75.85 ± 2.14 66.74 ± 1.91 0.01062 
MICA 673.65 ± 26.85 581.86 ± 24.91 0.01204 
IL22RA1 162.35 ± 15.93 140.07 ± 14.15 0.01371 
PSMB7 14021.10 ± 440.69 12979.44 ± 307.28 0.01710 
CD99 9202.72 ± 218.41 7421.10 ± 451.48 0.01940 
EWSR1 7060.98 ± 147.24 6397.58 ± 240.29 0.01945 
IL32 14114.88 ± 192.75 12173.38 ± 468.21 0.01956 
BST1 133.37 ± 4.12 118.26 ± 6.08 0.02019 
SAA1 13701.20 ± 2461.14 10812.05 ± 2102.12 0.02053 
TXNIP 6795.88 ± 583.26 5493.28 ± 508.51 0.02147 
IFI35 1320.91 ± 70.83 1134.87 ± 83.84 0.03119 
S100A12 147.15 ± 25.30 96.12 ± 34.67 0.03251 
CXCL16 3553.24 ± 29.85 3039.91 ± 90.17 0.03269 
ICAM3 247.92 ± 17.21 169.93 ± 7.93 0.03402 
MAPK11 50.37 ± 4.67 40.08 ± 3.49 0.03485 
MYD88 791.43 ± 40.11 733.22 ± 49.12 0.03581 
CXCL12 40.69 ± 8.06 28.98 ± 8.48 0.03824 
TP53 3425.43 ± 159.45 2979.50 ± 140.66 0.04366 
IL18R1 444.04 ± 5.74 363.54 ± 20.97 0.04893 





Figure 4.6: Ozonized 7-DHC increases IL-6 and IL-8 expression to a greater extent than 
ozonized cholesterol 
 20µM 7-DHC, cholesterol and the DMSO vehicle control were ozonized in buffer for 30 
minutes and immediately added to submerged 16HBE cultures for 1 hour. The same sterol 
solutions were also added to submerged cells without ozonization as a control. (A) IL-6 and (B) 
IL-8 expression was determined with qPCR. n=3. Data are presented as mean ± SEM. Statistical 







































































Table 4.3: DHCR7 Inhibiting Pharmaceutical Drugs 
Selected pharmaceutical drugs from the 2014 top 200 selling drugs in U.S. Drugs are organized 
by sales rank and Z-score for DHCR7 inhibitory effect in Neuro2A cells treated with 1μM 




Drug [Common Names] U.S. Sales Rank 2014 Z-score Drug Type
Metoprolol [Lopressor, Metolar] 6 63 β-blocker
Trazodone [Desyrel, Oleptro] 28 120 anti-depressant
Buspirone [Buspar] 95 110 anti-anxiety
Oxybutynin [Ditropan, Lyrinel] 107 30 anti-muscarinic
Donepezil [Aricept] 108 80 cholinesterase inhibitor
Aripiprazole [Abilify] 119 200 anti-psychotic
Risperidone [Risperdal] 128 10 anti-psychotic
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CHAPTER 5: IMPACT, NEW KNOWLEDGE GAPS, AND FUTURE STUDIES  
The work, both original and referenced in this dissertation, serve to answer pertinent 
questions regarding the biochemical mechanisms driving O3-induced inflammation, oxysterol-
protein adduction, and the potential for interaction between common pharmaceuticals and 
environmental pollutants. Despite providing new knowledge in these branches of research, fresh 
knowledge gaps emerge from our data and original investigations must be proposed to advance 
our collective knowledge. This chapter will underscore the fields of study that stand to be 
transformed due to the new data discussed in this manuscript with each section 1) synthesizing 
our key findings, 2) emergent knowledge gaps, and 3) proposed future studies. Our findings 
advance current knowledge on O3-induced inflammatory signaling, O3 exposure response, 
airway epithelial inflammasome activity, oxysterol-protein adduction, and drug-x-environment 
interaction, all of which can be expanded upon in future research endeavors. 
 
5.1 O3 Disruption of Sterol Homeostasis 
5.1.1 Key Findings 
 As discussed in previous chapters, we must note that any changes in cholesterol 
synthesis, sterol ratio, and sterol homeostasis can lead to cellular dysfunction and adverse health 
effects. Dysregulation of oxysterol levels, either by overexpression of CYP enzymes or deletion 
143 
 
of synthesis enzymes, impair induction of LXR target cholesterol transport genes and can lead to 
sterol overload and ultimately cell death (1). Chapter 2 presents compelling evidence that O3-
derived oxysterols adduct to LXR and influence the inflammatory response following O3 
exposure. Specifically, SecoA inhibits the transcription of sterol transport and binding proteins, 
increasing NF-κB activity and inflammatory cytokine signaling. It is of additional interest, 
however, that O3 exposure itself alters expression of genes that regulate cholesterol efflux, fatty 
acid synthesis, and cholesterol regulation. Our findings indicate that cholesterol availability is 
paramount to the formation of O3-derived oxysterols in the airway, suggesting novel targets to 
modify effects associated with ambient O3 exposure.  
5.1.2 Emergent Knowledge Gaps 
 Besides LXR-oxysterol adduction and impaired cholesterol transport gene expression we 
have little evidence regarding the effects of oxysterols on downstream LXR signaling and 
cellular functions following O3 exposure. We show that O3 exposure alone decreases the 
transcription of cholesterol transport genes regulated by LXR activity in human airway epithelial 
cells, however, it remains unknown whether the observed decrement in cholesterol transport 
could be associated with additional adverse health effects. LXR agonists have long been studied 
as a means to enhance airway immune response and attenuate diet-induced or genetic 
dyslipidemia (2). Additionally, KO mice deficient in cholesterol transport capabilities (e.g. 
ABCG1) experience poor innate and adaptive immune response to bacterial and environmental 
stressors in the lung suggesting cholesterol efflux enhances innate immune function. (3). Clinical 
reports also draw connections between “good” High Density Lipoprotein (HDL) cholesterol 
serum levels and positive airway proficiency test results (4,5). 
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Beyond the airway, it is possible that the cardiovascular events associated with O3 exposure may 
also be enhanced by dysregulation of cholesterol homeostasis due to air pollution. Epidemiologic 
and clinical studies show a correlation between high O3 pollution and increased cardiovascular 
events. O3 exposure can increase vasoconstriction, tachycardia, and increased mortality 
attributed to cardiopulmonary events (6-8). Further, O3-derived oxysterols SecoA and SecoB 
have been measured in atherosclerotic lesions and lipid overloaded macrophages, and could be a 
causative factor in the atherogenesis (9). Additionally, new evidence exists that air pollutants 
alter systemic cholesterol in humans leading to cardiovascular disease. Individuals living in areas 
with high traffic-related air pollution have lower levels of HDL and increased oxidized Low 
Density Lipoprotien (ox-LDL) a phenotype associated with cardiovascular disease (10,11). LXR 
activity and cholesterol homeostasis may be a key factor in protecting the airway from pollutant 
induced inflammatory diseases and certainly requires further study.  
5.1.3 Future Studies 
 Three main avenues of research present themselves in our newly uncovered knowledge 
gaps, 1) determining the extent to which O3 exposure alone alters sterol transport and binding 
mechanisms, 2) further elucidate the mechanism by which O3 derived oxysterols alter LXR 
signaling, and 3) analyze the association between respiratory/cardiovascular health and changes 
in LXR signaling and sterol content that start in the airway. First, cell line and animal knock out 
models for LXR, ABCA1, SREBP1 exposed to O3 should be evaluated by LC/MS for altered 
overall sterol profiles as well as response to the pollutant, revealing whether there is a synergistic 
effect between diminished cholesterol homeostatic signaling and environmental exposure. 
Second, the specific consequences of O3–derived oxysterol-LXR adduction can be elucidated by 
probing the LXR transcription pathway. For example, LXR activation occurs through 
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SUMOylation, conjugation and dimerization with RXR before transcribing cholesterol transport 
genes (12). O3 or SecoA exposed 16HBE cell lysate could be immunoprecipitated with RXR or 
SUMOylation antibodies and probed for LXR in order to determine if LXR adduction interferes 
with these steps leading to transcription. Third, animal model and clinical studies could examine 
the connections between LXR signaling and O3-induced adverse health effects. LXR agonists 
have already been proposed as a therapeutic target to reduce inflammatory disease progression in 
everything from liver disease, atherosclerosis, and to atopic dermatitis, however the specificity 
and potency of these treatments vary from tissue to tissue and few have been tested in the context 
of an environmental exposure (13-16). In the case of the airway, lipid metabolic therapy by LXR 
inducing agents may be able to suppress the generation of O3-derived oxysterols, reduce their 
uptake by pulmonary macrophages, and attenuate the progression of pulmonary diseases and 
atherogenesis. LXR agonists could be tested as a potential rescue treatment for mouse models of 
air pollutant induced acute lung injury and atherosclerosis. 
 
5.2 Oxysterols: A Piece of the O3-Induced Inflammation Puzzle 
5.2.1 Key Findings 
Ground level O3 air pollution has long been studied as a potent initiator of inflammation in the 
human airways, has been associated with various disease states, and exacerbation of existing 
disease. The mechanisms governing O3-induced inflammation however, have never been fully 
elucidated and represent a much studied “black-box” in understanding inflammation in the lung. 
Many mechanisms play a role in O3-induced inflammation and the research detailed in this 
dissertation describes a new piece of the puzzle. First, we now know that O3-derived oxysterols 
alone have the capacity to activate NF-κB signaling in 16HBE cells and we believe that 
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oxysterol-protein adduction is tied to this inflammatory response. Second, as discussed in chapter 
2, the LXR activation pathway is known to have a transrepressive effect on NF-κB inflammatory 
activity and oxysterol adduction to LXR may inhibit inflammation repression leading to greater 
induction of inflammatory cytokine signaling. Finally, we go further in chapter 3 to show that 
oxysterol-NLRP2 adduction may also play a part in O3-induced inflammation. Previous studies 
have already shown that IL-1β and IL-18 signaling induces NF-κB activity and increases levels 
of IL-6 and IL-8 (17). Our data supports this finding, connecting inflammasome activation with 
NLRP2 activity in 16HBE cells. Although we cannot confirm the link, NLRP2 inflammasome 
caspase-1 activity and subsequent cleavage of IL-18 and IL-1β, this process appears to regulate 
the expression of inflammatory cytokines IL-8 and IL-6. Our data support the notion that 
oxysterol formation and protein adduction in the human airways contribute to O3-induced 
inflammatory signaling pathways, presenting a novel field for additional studies. 
5.2.2 Emergent Knowledge Gaps 
New questions about the mechanisms behind O3-induced inflammation arise from our reported 
data. Foremost, the oxysterol-protein adductome needs to be more thoroughly examined as 
adduction to any of the reported proteins may change cellular function. The main oxysterol-
protein targets discussed in this dissertation were highly focused and may not reveal the extent 
that O3-derived oxysterols and protein adduction can impact cellular function. In Chapter 2, LXR 
was chosen as it is a known target for enzymatically derived oxysterols and in chapter 3 NLRP2 
was chosen out of our adductomics analysis based on its unique abundance in 16HBE cells and 
its proclivity as a sensor for damage associated molecular patterns among the other adducted 
targets. Thus, it is of interest to determine whether O3-derived oxysterol adduction of chaperone 
and cytoskeletal proteins alter cellular viability and health. Aldehydic adduction of chaperone 
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heat shock proteins has been shown to arrest cellular transcription and decrease HeLa cell 
viability (18) . Second, we must question whether oxysterol formation and adduction occurs 
specifically with O3 or could other free radical and oxidant pollutants also create oxysterols in 
the airway or elsewhere. Finally, the role of NLRP2 activity as a possible regulator of 
inflammatory signaling in human airway epithelial cells must be further elucidated. NLRP2’s 
abundance in airway epithelial cells may mean it has a prominent function outside of 
inflammasome assembly. NLRP2 could most likely be a sensor for damage and pathogen 
associated molecular patterns (DAMPs and PAMPs) aside from O3. Testing other agonists such 
as bacterial LPS or TNF-α may reveal if NLRP2’s response to O3 is specific. Finally, it is still 
unclear whether NLRP2 induced IL-18 and IL-1β presents a positive feedback mechanism 
inducing inflammatory cytokine transcription.  Answering these questions may further describe 
the mechanisms driving O3 induced inflammation and illuminate NLRP2’s undiscovered role in 
airway epithelial cells.  
5.2.3 Future Studies 
Despite presenting compelling data exemplifying novel biochemical mechanisms governing O3-
inuced inflammation, additional pieces of the puzzle need to be filled in by future studies. 
Crystalline structure analysis of adducted NLRP2 and LXR could provide better evidence of how 
O3-derived oxysterols influence normal protein activity. Further, a site directed mutagenesis 
study on NLRP2 activity could provide more clues regarding its specific mechanism in airway 
epithelial cells and deletion of the adducted lysine residue adducted prevents adduct induced 
inflammasome activation.  
Finally, our “adductomics” analysis already shows that oxysterol-protein adduction is not 
limited to NLRP2 and LXR and various other adducted protein targets may also be involved in 
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inflammatory response in the airway. A more in-depth study of the “adductome” including the 
location of adducts and possible conformation changes to protein structure need to be considered 
when evaluating the total influence oxysterol-protein adduction has on O3-induced inflammation 
in the airway epithelium. Chapter 2 focused on adduction of LXR, which we pursued since it was 
a known sensor for oxysterols and was indeed adducted by O3-derived oxysterols. NLRP2 was 
targeted in the second paper as a standout protein associated with inflammasome signaling 
adducted by SecoA, however, focusing on the many other adducted proteins was beyond the 
scope of this dissertation. Scaffolding, Cell cycle and Structural proteins were all highly 
adducted by SecoA and the potential adverse effects of their adduction needs to be discussed. 
Previous studies have shown the ability for electrophilic aldehydes like 4-HNE to adduct to 
cytoskeletal elements and alter cellular viability in various cell types (19,20). Clinically, 
cytoskeletal modification has been associated with adenocarcenomas, and lipid peroxidation 
product modification of microtubules may contribute to neuronal dysfunction and Alzheimer’s 
disease (20,21). In our airway epithelial cells, membrane and monolayer integrity could be 
measured by epithelial resistance and visualized using immunohistochemical staining for 
cytoskeletal elements in order to measure any deficit in cellular organization.   
 
5.3 Novel Target: NLRP2 in Airway Epithelial Cells 
5.3.1 Key Findings 
Although the focus of our translational minded research primarily examined the biochemical 
mechanisms of inflammation and adverse health effects following O3 exposure, I must stress the 
importance of our novel finding of NLRP2 as an abundant protein in the human airway 
epithelium. Finding NLRP2 in our list of adducted proteins was unexpected, as the unbiased 
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proteomics approach produced NLRP2 among mainly large and abundant chaperone, 
cytoskeletal, and histone proteins. Prior to these reported findings there was no record of NLRP2 
in human airway epithelium cells or a clearly described function in any human tissue. For the 
first time, our research revealed the high abundance of NLRP2 in both primary human airway 
epithelial cells and widely used human airway epithelial cell lines. Our data serves to clarify 
elements of its role in inflammasome activation, however, further studies are necessary.  
5.3.2 Emergent Knowledge Gap 
 Despite the distinctive finding of NLRP2 as a key player in airway epithelial cell 
response to damage associated molecular signal, like oxysterols, there is a significant gap of 
information regarding its function in the human body that needs to be addressed. Firstly, NLRP2 
was found to be highly abundant in human airway epithelial cells (on par with expression levels 
of β-actin and other highly expressed genes) it may have functions beyond inflammasome 
activation. We know O3 exposure can alter NLRP2 function, is it possible that other oxidant 
gasses and environmental exposures impact NLRP2 function. Second, we confirm that NLRP2 is 
clearly present in airway epithelial cell types but not in immune cells like monocytes and 
macrophages. The relative abundance of NLRP2 in different cell types creates an enigma for 
future studies, as especially in the airway, epithelial cells coexist with resident macrophages, 
which rely on inflammasome activity for pathogen response (22,23). Finally, NLRP2 may pose a 
significant target to study outside of the airway and may be a key cellular protein in epithelial 
cells in other tissues.  
5.3.3 Future Studies 
Additional research is necessary in order to better describe NLRP2 function in human airway and 
in the human body in general. Although the knowledge gaps regarding NLRP2 are vast, we can 
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start by examining NLRP2’s function as a whole and design tests to ascertain if NLRP2 can be 
targeted by environmental and pharmaceutical intervention.  NLRP2 is highly conserved in 
primates, however, studies evaluating NLRP2 in mouse models is not consistent in regards to its 
function (24). NLRP2 knockout mouse models reveal its primary role in embryogenesis but no 
change in the lung phenotype of the animal (25). Although present in mouse models, murine 
NLRP2 may not be a direct homologue of the human form. Creating a humanized NLRP2 mouse 
model would allow us to mimic its role in the human lung inflammasome assembly and better 
explain the mechanism by which environmental exposures illicit downstream inflammatory 
signaling in the human airway. In the case of O3-derived oxysterols, adduction appears to occur 
more readily with NLRP2 as compared to the more frequently studied NLRP3, meaning NLRP2 
may be an undervalued target for adverse cellular stress. Careful characterization of where 
NLRP2 is expressed in the human body is needed. The Human Protein Atlas provides only 
uncertain evidence regarding NLRP2, showing low RNA expression of NLRP2 in all tissue types 
with slightly more in the testes No protein level evidence for NLRP2 is recorded in the Human 
Protein Atlas. Thus, the cells in tissues frequently affected by oxidative stress should be assessed 
for NLRP2 presence and function. Endothelial cells in particular would be of interest as they are 
highly susceptible to oxysterol exposure as measured in atherosclerotic plaques. 
 
5.4 Intrinsic and Extrinsic Factors Determine O3 Exposure Response 
5.4.1 Key Findings 
In the field of O3 exposure research, primarily intrinsic factors such as age, sex and genetics have 
been considered when evaluating intensity of O3 response in an individual. Numerous clinical 
studies show that individuals exposed to O3 can be classified into two groups, responders and 
151 
 
non-responders, based on the reduction in forced exhalation volume (FEV) and neutrophil 
infiltration following exposure (26,27). The majority of current literature examining responders 
and non-responders indicate that these two classifications are primarily due to genetic 
predisposition to O3 exposure response by activity of the Glutatione-S-Transferase M1 (GSTM1) 
gene. GSTM1null individuals are thought to have a diminished capacity for resolving O3 induced 
inflammation and respond to the exposure more profoundly than those individuals with normal 
GSTM1 alleles (28-30). Similarly, in vivo mouse strain genomics studies reveal genetic 
mechanisms of susceptibility to O3 adverse health outcomes including TNF, TLR4 and MHC 
genes (31-33). While the intrinsic factor of genetics has explained some of the differential 
susceptibility in human O3 response, extrinsic stressors such as diet, and pharmaceutical drugs 
are now being considered. Obesity, while also frequently concomitant with asthma, appears to 
exacerbate the response to O3 exposure exhibited by decreased FEV measurements and increased 
levels of inflammatory mediators (34-36).  In addition, therapeutic studies using γ-tocopherol 
have already been shown to protect against air pollutants (37). Further, a potential impactful 
emerging extrinsic factor modifying susceptibility to O3 are pharmacological agents. Our 
research demonstrates that APZ and other small molecule drugs alter the sterol concentration 
profile in airway epithelial cells, potentiating O3 induced inflammation. By uncovering the 
susceptibility of the human airway to oxysterol generation and the tendency for drugs to modify 
available sterol ratios we have unveiled a new paradigm of study when looking at intensity of 
response to O3 exposure, drug-x-environment interaction. 
5.4.2 Emergent Knowledge Gaps 
As stated, the data we present in previous chapters examining oxysterols and drug-x-
environment interaction adds another possible clue to the responder/non-responder mystery. Our 
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data provides evidence that O3-derived oxysterols do have the capacity to increase inflammation 
in airway epithelial cells. Thus, pharmacological agents with either the designed or off target 
effect of modifying cholesterol biosynthesis can control the amount and ratio of oxysterol 
species being formed. Statins, drugs meant to inhibit HMG-CoA reductase at the beginning of 
cholesterol synthesis, have shown promise in some epidemiological studies in their ability to 
attenuate asthma and response to air pollution, however no conclusive clinical evidence has been 
reported (38,39). Statins could act to reduce O3 induced inflammation by decreasing the pool of 
available cholesterol and presenting reduced levels of targets for ozonization during exposure. 
Whether statins can protect the airway from pollutants by altering the cholesterol constituency of 
the airway surface liquid and species oxysterols formed following O3 exposure is worth 
exploring. Broadening our focus on the other widely used pharmaceuticals with off target effects 
inhibiting cholesterol synthesis enzymes like DHCR7 is prudent and it is currently unknown 
what combinations of drugs or pollutants could induce adverse effects. Inhibition of DHCR7 
increases the levels of cholesterol precursor 7-DHC, a species more susceptible to ozonization 
and increasing the probability a highly reactive species will be formed. Thus, a current 
knowledge gap is whether there is a correlation between adverse health effects, high pollutant 
days, and pharmaceutical consumption.  
5.4.3 Future Studies 
In order to fulfill the new questions posed by our research, more intensive human pollutant 
exposure studies or epidemiological association studies need to be undertaken. Accordingly, O3 
exposure studies utilizing human volunteers should include the collection of data that could 
inform researchers of potential differences in cholesterol composition between individuals. For 
example, total cholesterol and sterol content could be evaluated in blood samples of volunteers 
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collected pre exposure. Alternatively, IRB protocols could be developed to undertake a 
controlled O3 exposure study in individuals taking APZ and compare them to individuals with no 
prescribed drug use. Consequently, drugs known to modify sterol levels, even as an off target 
effect, should be recorded in a subject’s medical file, if not used as an exclusion criteria from the 
study, to allow for retrospective association studies and inform any O3 response data. Second, a 
drug screening process, similar to what is undertaken studying potentially adverse chemicals 
with ToxCast™, can be used to reveal the potential for additional pharmaceuticals to alter 
cholesterol synthesis in various cell types, which could be considered for interaction with 
pollutants such as O3. Instead of measuring toxicity, each drug or chemical could be screened for 
alterations in sterol profiles in the cell type of choice. Finally, drug x environment interaction 
studies could be undertaken through bioinformatics analysis and data mining of already existing 
air pollution and human response databases. Studies of this kind have previously evaluated 
geographic information systems considering ambient air pollution correlation with COPD 
hospitalizations in Jinan China (40). Similarly, the current status of machine learning algorithms, 
and new technologies in gathering pollution sensor data provide for large scale studies evaluating 
epidemiological data (41). UNC and North Carolina is a prime location to undertake such a study 
by assessing relationships between the thorough regional air quality monitoring, UNC hospital’s 
records of adverse respiratory and cardiovascular events, and patient prescription histories.  
Considering the high percentage of Americans taking daily pharmaceuticals and the 
compounding factor that individuals already considered susceptible due to intrinsic factors may 
be prescribed various medications, our research may have defined a new archetype when 
evaluating environmental exposure response. The relationship between prescribed 
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pharmaceuticals and environment should be considered in any new environmental exposure 
study or drug safety assessment. 
 
5.5 Overall Impact  
Evaluating the research described in previous chapters as a whole, the findings advance basic 
science regarding airway epithelial cell biology as well as provide new avenues for translational 
clinical research examining at respiratory health and air pollution. Although we have filled some 
of our originally proposed knowledge gaps, the major issues we have assessed will not be 
resolved by this research alone and there is much more to accomplish regarding the investigation 
of O3 induced inflammation, oxysterols, NLRP2, and drug x environment interaction.  
In my opinion, foremost among our findings is the potential for pharmaceutical drugs to 
interact with environmental pollutants. The ingredients for O3 formation; atmospheric sunlight, 
heat, and volatile organic compounds (VOCs), are unlikely to decrease in the near future. 
Ground level O3 levels in the U.S. much of Europe and Japan may have decreased over the past 
25 years, however, marked increases in newly industrialized countries has increased the total 
global O3 pollution (42). Compounding the growth of pollution, many of the countries with 
increasing industrial concerns, automobile exhaust, and other sources of VOCs exist near the 
equator and experience the highest temperatures and sunlight hours leading to massive creating 
of O3 air pollution (43). Further, Climate change research indicates that any increase in global 
temperature may increase O3 generation in the atmosphere (44). Although ground level O3 serves 
as a well-established example to examine adverse health effects and drug interaction effects, 
other environmental pollutants may be additional relevant targets of interest to pursue. On a 
similar track, pharmaceutical drug use shows no signs of anything but exponential growth in the 
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near future. The FDA alone approves approximately 50 novel drug formulations per year and 
studies have shown that almost 60% of the U.S. population takes at least one prescription drug 
(45). Taken together, the potential for drug-x-environment interaction may be the greatest threat 
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